rfhg_147597.1

Basic information about the TSS

---

TSS ID: rfhg_147597.1 Species: human Chr: chr12		Start: 11649614 End: 11649626 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2529889,EH38E1592765)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000396373.9:48 GeneID: 2120 HGNC/MGI_ID: HGNC:3495 UniProt_ID: A0A0S2Z3C9 Nearer transcript ids and distances: AK289441:126 BC043399:228 ENST00000541426.1:318 MK172837:375 ENST00000544715.1:385 MK172836:477 U11732:478 view more...

Gene_name: ETS variant transcription factor 6 Gene_symbol: ETV6 Gene_synonyms: TEL Gene_source: HGNC:3495

TATA-Box annotation

---

Distance to TSS:	-234
Nearest PromoterID:	NM_001987
Entrez ID:	2120
Nearest Unigene:	Hs.504765
Nearest Refseq:	NM_001987
Nearest Ensembl:	ENSG00000139083
Gene Name:	ETS variant transcription factor 6
Gene Alias:	TEL|TEL/ABL|THC5
Gene Type:	protein-coding
CpG%:	0.083333
GC%:	0.461538
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ETV6 p2@ETV6 p3@ETV6 p4@ETV6 p5@ETV6 p6@ETV6 p7@ETV6 p8@ETV6
Sample		p1@ETV6	p2@ETV6	p3@ETV6	p4@ETV6	p5@ETV6	p6@ETV6	p7@ETV6	p8@ETV6
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	4.68	0.00	0.19	0.00	0.39	0.58	0.00	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	5.26	0.20	0.00	0.00	0.20	0.40	0.00	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	4.44	0.39	0.00	0.00	0.77	0.19	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	2.49	0.42	0.21	0.21	0.21	0.21	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	4.05	0.45	0.22	0.00	0.00	0.67	0.22	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	6.40	0.00	0.19	0.00	0.19	0.39	0.19	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	3.70	0.22	0.00	0.00	0.00	0.22	0.22	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	3.88	0.24	0.48	0.00	0.48	0.00	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	4.06	0.64	0.00	0.00	0.21	0.21	0.00	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	4.06	0.58	0.00	0.00	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	5.26	1.21	0.00	0.40	0.00	0.00	0.40	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	7.32	0.81	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	4.51	0.48	0.00	0.32	0.16	0.16	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	4.21	0.30	0.30	0.15	0.15	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	3.95	0.88	0.00	0.22	0.00	0.22	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	4.28	1.26	0.00	0.25	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	6.33	0.44	0.00	0.00	0.00	0.22	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	6.33	0.84	0.00	0.00	0.42	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	2.13	0.53	0.00	0.00	0.00	0.00	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	5.27	0.45	0.00	0.00	0.30	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	5.21	0.53	0.27	0.13	0.13	0.00	0.13	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	5.87	0.52	0.35	0.00	0.00	0.00	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	3.75	0.65	0.39	0.00	0.00	0.39	0.00	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	4.37	0.73	0.73	0.24	0.00	0.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	6.97	0.77	0.26	0.26	0.26	0.00	0.00	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	4.43	0.95	0.00	0.00	0.32	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	4.95	0.00	0.00	0.00	0.55	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	7.31	1.65	0.47	0.24	0.00	0.47	0.94	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	5.33	1.13	0.81	0.00	0.00	0.00	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	4.89	0.90	0.36	0.00	0.36	0.36	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	6.91	1.67	0.84	0.00	0.21	0.00	0.42	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	6.06	1.56	2.15	0.00	0.00	0.20	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	8.23	1.48	0.21	0.00	0.00	0.63	0.63	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	10.72	1.98	2.31	0.16	0.16	0.00	0.16	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	7.48	1.12	1.31	0.00	0.37	0.93	0.00	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	6.90	1.15	0.00	0.96	0.00	0.19	0.19	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	8.38	2.86	1.43	0.20	0.20	0.20	0.61	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	6.25	1.81	1.21	0.60	0.20	0.00	0.40	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	7.56	0.81	2.16	0.00	0.27	0.00	0.27	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	11.04	1.20	0.96	0.24	0.00	0.24	0.72	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	7.76	3.29	0.71	0.24	0.24	0.47	0.94	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	9.52	1.90	0.88	0.29	0.29	0.00	1.32	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	12.86	2.95	0.63	0.63	0.00	0.21	1.05	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	11.71	2.62	1.05	0.35	0.17	0.00	0.52	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	12.25	2.81	0.80	0.60	0.00	0.00	0.80	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	9.31	3.95	0.93	0.70	0.23	0.23	0.23	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	9.60	4.56	1.44	0.48	0.24	0.00	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	8.35	3.28	0.30	0.00	0.30	0.30	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	9.57	2.39	0.48	0.24	0.48	0.48	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	10.51	1.42	0.61	1.21	0.00	0.20	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	10.66	2.46	1.23	0.61	0.00	0.00	0.41	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	11.56	2.67	0.67	0.44	0.67	0.22	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	55.97	13.99	13.99	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	5.32	3.19	0.71	1.06	0.35	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	6.96	2.32	0.66	0.33	0.66	0.33	0.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	20.97	2.52	0.84	0.00	0.84	1.68	0.00	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	11.48	2.30	0.92	0.46	0.92	0.46	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	8.75	1.94	0.65	0.00	0.32	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	7.39	2.57	1.28	0.64	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	13.20	1.89	0.94	0.63	0.00	0.31	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	7.76	3.53	1.41	0.71	0.00	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	9.53	1.68	1.12	0.56	0.00	1.12	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	49.36	0.00	6.37	3.98	1.59	0.80	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	19.37	3.74	1.02	0.34	0.34	0.00	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	10.40	2.27	0.65	0.00	0.65	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	11.36	1.06	0.00	0.35	0.00	0.35	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00	0.00	0.00	32.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	31.59	31.59	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	3.41	1.46	0.00	0.98	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	2.48	1.49	0.50	0.00	0.00	0.50	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	7.51	1.41	0.94	0.47	0.00	0.94	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	3.64	0.33	0.33	0.00	0.00	0.00	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	4.64	0.31	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	4.89	0.92	0.00	0.00	0.31	0.00	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	9.82	0.79	0.48	0.16	0.32	0.16	0.32	0.00
Adipocyte - breast, donor2	11327-117E4	10.11	1.28	0.48	0.16	0.32	0.64	0.48	0.00
Adipocyte - omental, donor1	11473-119C6	10.31	0.89	0.89	0.25	0.38	0.38	0.38	0.00
Adipocyte - omental, donor2	11474-119C7	5.98	2.24	0.75	0.75	0.00	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	8.04	2.01	0.00	0.00	0.33	0.00	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	7.66	1.28	0.00	0.64	1.28	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	5.50	2.20	1.10	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	4.97	0.90	0.00	0.45	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	4.34	0.87	0.17	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	23.66	5.67	0.20	0.78	0.59	0.59	0.20	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	22.39	5.40	0.77	1.03	0.00	0.26	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	20.35	1.39	1.12	1.12	0.00	0.28	0.56	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	13.52	2.35	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	14.40	3.70	0.72	0.72	0.24	0.16	0.56	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	16.78	2.58	0.32	2.90	0.32	0.65	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	12.26	1.07	0.53	1.07	0.00	0.00	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	6.12	0.56	0.00	0.56	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	9.15	0.42	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	10.30	3.77	0.25	1.00	0.25	0.00	0.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	11.78	1.64	0.98	0.00	0.00	0.33	0.33	0.98
Adipocyte differentiation, day12, donor4	13030-139E6	9.13	0.91	0.30	0.00	0.00	0.30	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	5.52	1.33	0.44	0.22	0.44	0.22	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	5.02	0.72	0.00	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	7.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	5.94	0.54	0.00	0.18	0.18	0.36	0.18	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	1.67	1.67	0.00	1.67	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	6.99	0.62	0.21	0.21	0.00	0.00	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	5.84	1.49	1.03	0.23	0.11	0.11	0.00	0.00
Anulus Pulposus Cell, donor2	11463-119B5	5.14	1.96	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	8.99	0.90	0.00	0.00	0.00	0.00	0.45	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	5.64	2.17	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	4.28	4.28	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	9.57	2.39	0.60	0.00	0.30	0.30	0.30	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	5.06	1.26	1.26	1.26	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	5.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	4.22	0.65	1.30	0.32	0.32	0.00	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	7.28	2.43	0.49	0.00	0.00	0.49	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	6.53	0.59	1.19	0.00	0.59	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	10.92	2.64	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	8.71	2.18	0.73	0.00	0.00	0.00	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	2.51	0.00	1.25	0.00	1.25	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	8.24	1.98	0.66	0.00	0.49	0.00	0.16	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	5.46	4.09	0.00	0.00	0.00	0.00	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	4.52	1.36	0.30	0.00	0.15	0.15	0.30	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	4.82	3.21	0.00	0.54	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	8.31	3.40	0.76	0.38	0.00	0.19	0.00	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	10.16	2.41	0.80	0.00	0.00	0.00	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	6.83	1.95	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	7.13	1.66	0.50	0.33	0.00	0.33	0.33	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	0.00	1.20	2.40	0.00	2.40	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	7.08	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	6.52	2.40	0.86	0.00	0.17	0.34	0.34	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	6.31	1.46	0.49	0.49	0.49	0.00	0.49	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	7.97	5.69	1.52	0.00	0.38	0.00	0.76	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	12.11	3.63	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	9.12	1.14	0.57	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	8.98	3.63	0.21	0.21	0.00	0.00	0.43	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	5.94	1.29	0.52	0.26	0.00	0.26	0.00	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	7.98	1.88	0.47	0.00	0.00	0.00	0.47	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	7.40	2.25	0.64	0.64	0.64	0.00	0.64	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	5.71	1.43	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	2.92	1.17	1.17	0.58	0.00	0.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	8.13	1.81	0.30	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	3.56	2.38	1.19	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	7.12	3.56	0.51	0.00	0.00	0.00	0.51	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	8.66	2.55	0.25	0.25	0.76	0.51	0.25	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	5.08	1.27	0.00	0.64	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	6.04	1.73	0.43	0.43	0.00	0.00	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	6.77	0.64	0.42	0.42	0.21	0.00	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	4.06	0.58	0.58	0.00	0.29	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	6.61	3.78	0.94	0.00	0.00	0.00	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	8.48	1.53	0.34	0.51	0.17	0.00	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	6.95	0.00	2.32	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	4.23	2.11	2.11	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	6.86	1.50	0.43	0.43	0.21	0.21	0.21	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	6.62	0.60	1.20	0.00	0.00	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	9.48	2.19	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	4.37	2.30	1.61	0.46	0.00	0.23	0.00	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	10.20	5.10	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	3.81	0.76	0.25	0.25	0.25	0.25	0.51	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	6.61	1.86	0.62	0.21	0.21	0.00	0.21	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	5.20	1.22	0.31	0.31	0.00	0.61	0.00	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	8.13	0.96	0.48	0.00	0.48	0.48	0.48	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	5.77	2.88	0.44	0.22	0.67	0.00	0.22	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	7.63	3.05	0.00	0.00	0.00	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	8.31	0.00	0.55	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	6.88	2.38	0.00	0.53	0.00	0.26	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	5.45	2.54	0.73	0.00	0.00	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	16.95	4.54	1.23	0.12	0.61	0.37	0.61	0.25
Astrocyte - cerebellum, donor2	11580-120F5	10.10	3.94	0.68	0.17	0.17	0.17	0.86	0.00
Astrocyte - cerebellum, donor3	11661-122F5	13.42	2.31	0.63	0.42	0.42	0.63	0.63	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	15.69	6.97	3.49	0.35	0.35	0.00	0.35	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	18.12	7.12	1.13	0.49	0.65	1.13	0.49	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	14.77	6.86	1.94	0.75	1.19	0.45	0.60	0.89
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	33.60	57.69	4.82	6.31	1.83	0.57	1.49	1.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	33.20	46.35	5.39	5.01	2.13	0.75	1.75	1.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	25.49	43.36	5.23	3.41	1.71	1.02	2.05	1.14
Basophils, donor1	12241-129G9	25.11	15.95	2.09	2.88	1.05	0.26	1.57	0.52
Basophils, donor2	12242-129H1	30.31	14.79	1.44	3.97	0.72	0.36	1.44	0.00
Basophils, donor3	12243-129H2	28.52	23.81	3.09	5.29	0.73	0.59	1.18	1.03
Bronchial Epithelial Cell, donor1	11511-119G8	14.66	0.43	0.00	0.22	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	11.89	1.37	0.46	0.00	0.46	0.46	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	7.17	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	6.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	8.11	1.46	0.00	0.21	0.21	0.42	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	10.59	0.23	0.23	0.00	0.23	0.46	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	7.74	0.54	0.00	0.36	0.00	0.00	0.18	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	11.54	6.60	1.24	0.52	2.68	1.34	0.82	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	37.03	10.95	2.33	2.10	5.82	1.63	0.93	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	86.66	72.59	6.40	3.20	28.14	7.99	3.20	2.56
CD133+ stem cells - cord blood derived, pool1	12223-129E9	82.74	124.10	10.34	0.00	51.71	20.68	20.68	0.00
CD14+ Monocytes, donor1	11224-116B9	64.81	65.94	3.38	5.07	0.56	2.82	1.13	1.13
CD14+ Monocytes, donor2	11305-117B9	61.25	80.74	3.90	11.69	1.30	1.30	0.93	3.34
CD14+ Monocytes, donor3	11381-118B4	54.88	58.84	3.29	10.32	0.66	0.88	0.66	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	21.51	14.72	2.83	0.85	0.00	0.28	0.85	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	33.36	9.86	1.90	1.90	1.14	0.38	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	44.38	24.33	1.97	4.27	0.33	0.33	0.66	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	80.22	62.73	6.94	10.70	2.02	0.87	1.88	2.46
CD14+ monocytes - mock treated, donor2	11873-125C1	54.01	50.69	7.24	5.43	1.51	0.30	2.41	2.41
CD14+ monocytes - mock treated, donor3	11883-125D2	75.33	87.89	10.90	9.71	2.61	1.42	1.66	1.42
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	65.45	47.54	4.35	4.02	1.34	1.00	1.67	1.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	38.92	51.34	6.62	7.18	1.66	1.10	2.48	1.10
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	46.61	62.97	6.69	6.69	1.24	0.74	2.23	0.99
CD14+ monocytes - treated with BCG, donor1	11860-125A6	56.59	76.17	6.07	5.48	1.76	0.98	1.37	3.13
CD14+ monocytes - treated with BCG, donor2	11870-125B7	54.66	84.57	8.01	11.22	1.25	0.36	2.67	3.03
CD14+ monocytes - treated with BCG, donor3	11880-125C8	54.84	109.90	12.40	10.01	2.18	0.87	2.83	2.61
CD14+ monocytes - treated with Candida, donor1	11868-125B5	52.91	55.49	4.68	4.92	1.64	0.00	0.94	1.64
CD14+ monocytes - treated with Candida, donor2	11878-125C6	52.27	71.28	2.64	6.86	1.06	1.58	1.06	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	32.17	77.66	3.33	8.87	1.11	2.22	2.22	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	68.57	55.33	4.31	6.10	1.64	1.64	1.93	1.49
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	50.09	48.29	4.39	6.98	2.59	0.40	1.60	1.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	55.38	62.04	8.54	5.41	3.12	1.25	3.54	2.91
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	97.92	75.27	7.32	8.47	2.97	0.69	2.97	2.29
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	73.29	79.40	10.63	5.66	2.94	1.58	2.94	2.04
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	73.33	95.58	9.17	8.73	1.31	1.31	1.31	1.75
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	58.37	104.64	5.11	7.26	0.81	1.08	1.61	2.96
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	65.77	129.62	10.64	8.20	0.52	0.35	2.97	2.62
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	58.49	160.75	15.99	10.52	1.68	1.68	4.21	2.95
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	72.38	69.44	5.70	8.45	1.84	1.29	1.29	0.55
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	69.04	61.29	3.52	8.81	1.41	1.41	2.82	1.41
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	83.80	90.38	8.34	7.90	3.51	2.19	0.88	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	51.79	74.63	6.28	8.72	2.62	1.22	1.39	2.09
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	43.49	70.99	8.92	7.43	1.86	1.12	2.97	1.86
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	59.06	110.15	13.80	9.48	1.29	1.29	4.53	5.39
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	64.70	53.23	3.28	5.32	2.87	0.41	1.23	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	57.25	60.73	8.58	3.94	1.16	0.70	2.55	2.09
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	60.78	79.34	8.58	5.57	1.86	1.16	3.25	3.71
CD14+CD16+ Monocytes, donor1	11789-124B7	22.67	20.05	1.31	2.83	0.22	0.00	0.22	0.65
CD14+CD16+ Monocytes, donor2	11801-124D1	35.57	19.40	2.31	4.16	0.00	0.00	0.92	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	23.18	19.06	1.08	4.12	0.65	0.65	0.43	0.87
CD14+CD16- Monocytes, donor1	11788-124B6	49.99	43.60	3.58	2.80	0.47	0.93	1.40	0.62
CD14+CD16- Monocytes, donor2	11799-124C8	36.68	27.42	3.14	2.97	0.00	0.70	0.35	1.05
CD14+CD16- Monocytes, donor3	11910-125G2	53.74	55.07	3.57	6.02	0.67	0.67	1.56	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	30.37	7.66	0.00	4.08	0.26	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	29.86	5.93	0.44	3.51	0.22	0.00	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	31.79	8.21	0.63	4.21	0.00	0.42	0.21	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	12.19	6.10	0.00	6.10	0.00	0.00	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	15.59	10.85	0.00	2.03	0.68	0.00	1.36	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	18.64	7.25	0.00	1.04	1.04	0.00	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	20.26	8.00	0.00	3.20	0.00	0.00	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	25.20	8.04	1.61	2.68	0.00	1.07	1.07	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	22.46	7.72	1.40	2.81	0.00	0.70	1.40	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	21.96	13.33	0.00	3.14	0.00	0.78	1.57	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	15.82	10.55	1.32	3.95	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	51.78	13.15	0.82	7.40	0.82	0.00	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	37.72	18.86	0.00	7.25	0.00	0.00	0.00	1.45
CD19+ B Cells, donor3	11705-123B4	49.98	18.17	1.51	8.08	1.01	0.50	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	3.64	0.40	1.21	0.00	1.62	0.40	0.81	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	5.99	1.60	0.40	0.00	1.20	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	43.17	72.29	8.03	1.00	13.05	1.00	2.01	3.01
CD34+ Progenitors, donor2	11625-122B5	63.48	67.98	7.30	3.37	14.05	2.81	6.18	3.37
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	57.49	40.96	5.64	1.88	17.66	4.88	1.13	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	53.21	43.52	7.22	1.35	20.52	4.96	1.80	1.13
CD4+ T Cells, donor1	11225-116C1	51.77	21.42	0.36	5.00	2.86	1.79	0.36	0.00
CD4+ T Cells, donor2	11306-117C1	59.40	22.66	0.00	7.35	1.84	2.45	0.61	0.61
CD4+ T Cells, donor3	11382-118B5	35.68	14.94	1.52	4.88	1.52	2.74	1.22	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	13.78	2.04	0.00	1.02	0.00	0.26	0.51	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	15.05	1.80	0.00	0.67	0.00	0.67	0.00	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	11.21	2.59	0.00	0.86	0.00	0.57	0.57	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	13.27	1.90	0.47	1.90	0.47	1.42	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	22.47	1.40	0.00	0.70	0.00	0.70	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	16.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	32.52	7.51	0.43	1.01	0.72	1.30	0.43	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	15.93	3.39	0.17	1.69	0.51	0.51	0.17	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	17.41	5.32	0.16	0.97	0.00	0.16	0.16	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	20.17	5.38	0.90	1.34	1.34	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	16.77	10.48	0.70	2.10	1.05	1.40	0.70	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	23.32	8.36	0.00	1.76	0.88	0.00	1.76	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	26.14	6.75	0.00	1.69	1.26	1.26	0.42	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	19.74	8.73	0.62	1.04	1.25	0.42	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	16.37	5.01	0.00	0.67	0.67	0.67	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	35.62	7.61	0.27	1.36	0.82	1.36	1.36	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	41.80	8.58	0.00	2.68	0.54	1.61	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	17.93	5.38	0.00	3.59	0.00	1.79	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	32.26	11.50	0.74	1.85	0.56	1.85	0.74	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	26.21	7.15	0.22	0.65	0.43	1.73	0.22	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	22.91	5.67	0.21	1.26	0.84	0.21	0.21	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	37.41	8.09	0.00	4.04	2.02	1.52	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	45.06	13.43	0.87	4.77	3.47	2.60	1.73	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	40.97	13.51	2.61	3.92	0.44	0.87	0.44	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	25.24	10.89	0.49	0.00	0.99	2.47	1.48	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	17.54	8.31	0.00	0.92	0.00	0.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	20.94	6.98	0.00	1.40	2.79	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	31.57	8.86	0.83	2.22	1.11	1.94	1.11	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	32.64	10.06	0.25	2.45	0.74	1.72	0.98	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	16.94	6.16	0.00	0.00	0.00	6.16	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	33.30	11.46	1.43	1.43	1.07	1.07	0.36	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	22.16	6.92	1.38	1.38	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	32.74	8.84	0.33	2.62	0.98	0.00	1.31	0.00
CD8+ T Cells, donor2	11307-117C2	25.90	9.01	0.38	3.75	1.13	0.38	1.50	0.38
CD8+ T Cells, donor3	11383-118B6	24.24	7.32	0.25	3.53	0.50	0.25	0.76	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	2.29	6.19	2.52	0.92	0.00	0.23	1.61	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	1.68	6.47	3.59	0.48	0.24	0.00	0.24	0.96
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	1.92	6.02	3.01	0.27	0.55	0.00	1.37	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	1.80	6.60	3.60	0.90	0.00	0.30	1.20	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	2.16	7.44	2.64	0.72	0.00	0.00	1.20	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	2.96	8.41	2.05	0.23	0.00	0.23	1.14	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	1.96	7.60	3.26	0.22	0.00	0.22	0.22	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	1.32	6.32	2.90	0.26	0.26	0.00	1.58	1.32
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	3.05	7.97	2.81	0.23	0.23	0.00	0.70	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	1.81	7.85	5.13	0.30	0.30	0.00	2.11	2.42
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	2.61	7.55	2.91	0.58	0.00	0.29	1.45	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	2.66	11.46	3.20	0.27	0.00	0.00	2.13	1.33
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	1.75	13.57	3.06	3.06	0.44	0.00	1.75	2.63
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	3.19	13.66	2.73	0.91	0.00	0.00	0.00	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	2.98	5.22	5.97	0.00	0.75	0.00	1.49	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	1.08	7.56	2.52	0.00	0.00	0.36	0.72	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	0.58	8.34	3.16	1.15	0.00	0.00	1.15	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	1.41	7.78	3.30	0.47	0.00	0.00	1.41	0.94
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	1.58	13.63	2.85	0.32	0.00	0.00	1.90	0.95
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	2.46	9.53	1.23	0.92	0.00	0.00	0.92	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	2.24	4.49	1.60	0.32	0.00	0.00	1.60	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	1.91	8.41	0.76	1.53	0.00	0.00	1.91	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	3.55	7.88	2.76	1.58	0.00	0.39	0.39	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	3.03	8.32	2.27	0.00	0.00	0.00	0.76	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	7.23	14.45	0.80	1.61	0.80	0.00	3.21	2.41
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	13.99	13.99	4.20	2.10	0.00	0.00	3.50	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	7.01	16.03	1.00	2.00	0.00	1.00	2.00	1.00
Cardiac Myocyte, donor1	11525-119I4	10.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	11.86	1.98	0.49	0.00	0.49	0.00	0.00	0.49
Cardiac Myocyte, donor3	11686-122I3	6.52	2.42	0.32	0.11	0.00	0.21	0.32	0.11
Chondrocyte - de diff, donor1	11261-116G1	8.32	1.04	0.35	0.35	0.00	0.35	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	10.31	3.20	2.13	0.36	0.36	0.36	1.07	0.00
Chondrocyte - de diff, donor3	11410-118E6	9.44	2.62	0.57	0.23	0.34	0.11	0.00	0.23
Chondrocyte - re diff, donor2	11339-117F7	17.91	6.27	2.69	0.90	0.90	0.00	0.90	0.90
Chondrocyte - re diff, donor3	11411-118E7	12.13	7.28	0.81	0.81	0.00	0.00	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	12.97	5.39	2.87	0.23	0.80	0.11	1.38	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	9.83	5.99	1.92	0.00	0.21	0.21	1.07	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	13.27	7.17	2.74	0.18	0.80	0.44	1.06	0.44
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	28.89	13.39	2.66	2.48	0.28	0.73	1.28	0.64
Corneal Epithelial Cells, donor1	11526-119I5	8.12	2.63	0.44	0.22	0.00	0.22	0.22	0.00
Corneal Epithelial Cells, donor2	11606-120I4	9.10	0.00	1.14	0.00	0.00	0.00	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	8.95	2.05	0.00	0.26	0.26	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	8.42	30.54	7.92	0.83	0.66	0.00	3.80	1.65
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	5.99	38.48	9.46	0.95	0.32	0.32	2.21	1.89
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	0.00	31.06	6.90	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	7.78	24.30	6.37	0.54	0.43	0.00	1.84	1.30
Dendritic Cells - plasmacytoid, donor1	11228-116C4	14.35	92.58	7.17	4.44	1.37	1.02	4.44	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	15.67	72.47	3.26	3.26	0.65	0.00	3.26	1.96
Dendritic Cells - plasmacytoid, donor3	11385-118B8	16.45	84.69	5.32	2.90	0.48	0.00	6.29	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	15.51	7.50	1.83	0.17	0.33	0.50	0.17	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	12.32	4.11	1.17	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	18.38	9.33	2.83	0.00	0.28	0.28	0.85	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	11.80	5.50	0.00	0.00	0.00	0.39	1.18	0.39
Endothelial Cells - Artery, donor1	11264-116G4	12.80	6.11	1.16	0.29	0.29	0.58	0.29	0.29
Endothelial Cells - Artery, donor2	11341-117F9	24.94	12.94	1.41	1.88	1.41	0.94	0.47	0.47
Endothelial Cells - Artery, donor3	11413-118E9	12.27	6.84	0.53	0.18	1.23	0.18	0.00	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	12.63	8.20	1.33	0.22	0.89	0.22	0.44	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	9.74	9.43	1.83	0.30	0.61	0.00	0.30	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	22.83	7.61	2.54	0.00	0.56	0.00	0.56	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	8.91	6.24	1.78	0.00	0.59	0.00	1.49	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	8.33	5.21	1.56	0.52	0.00	0.52	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	9.22	12.19	1.28	0.28	0.85	0.71	0.43	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	15.20	7.60	2.00	0.00	0.80	0.40	1.60	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	21.49	5.24	1.05	0.52	0.00	0.00	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	32.80	16.65	2.24	1.24	1.49	0.75	0.37	0.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	25.20	11.73	0.22	0.65	0.00	0.65	0.43	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	23.81	10.63	1.10	1.10	0.24	0.73	0.61	0.00
Endothelial Cells - Vein, donor1	11267-116G7	23.89	6.83	1.14	0.00	0.00	1.14	0.00	2.28
Endothelial Cells - Vein, donor2	11344-117G3	18.86	6.29	0.00	0.70	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	19.63	6.75	0.94	0.47	0.63	0.63	0.79	0.00
Eosinophils, donor1	12244-129H3	15.25	45.74	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	80.86	161.73	4.95	16.50	3.30	0.00	3.30	1.65
Eosinophils, donor3	12246-129H5	82.04	114.14	7.13	10.70	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	9.04	0.73	0.24	0.00	0.00	0.24	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	14.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	9.44	2.05	0.82	0.82	0.00	0.00	0.00	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	3.28	0.11	0.22	0.11	0.00	0.11	0.00	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	8.13	1.41	0.22	0.22	0.11	0.00	0.00	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	11.64	3.40	0.85	0.36	0.36	0.24	0.73	0.49
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	10.51	3.55	0.68	0.14	0.27	0.27	0.27	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	8.12	2.21	0.21	0.42	0.00	0.32	0.21	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	16.60	2.11	0.26	0.79	0.00	0.53	0.53	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	8.64	1.99	0.00	0.66	0.33	0.33	0.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	14.52	0.91	1.81	0.00	0.45	0.45	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	21.98	6.82	0.00	0.00	0.76	0.00	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	7.89	3.00	0.95	0.32	0.16	1.10	0.32	0.16
Fibroblast - Cardiac, donor4	11452-119A3	10.31	2.73	0.61	0.30	0.00	0.30	0.30	0.30
Fibroblast - Cardiac, donor5	11456-119A7	12.82	4.70	0.51	0.38	0.38	0.13	0.76	0.00
Fibroblast - Cardiac, donor6	11460-119B2	7.73	3.03	0.45	0.15	0.15	0.15	0.76	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	10.05	3.62	1.47	0.00	0.54	0.54	1.21	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	3.88	1.73	0.86	0.00	0.00	0.00	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	19.04	2.93	1.46	1.46	2.93	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	10.38	1.15	0.23	0.46	0.00	0.46	0.23	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	7.46	2.71	0.17	0.00	0.00	0.17	0.34	0.17
Fibroblast - Dermal, donor1	11269-116G9	3.99	0.94	0.00	0.23	0.00	0.47	0.23	0.00
Fibroblast - Dermal, donor2	11346-117G5	3.77	3.30	0.47	0.00	0.00	0.00	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	2.90	0.97	0.12	0.24	0.00	0.36	0.12	0.00
Fibroblast - Dermal, donor4	11450-119A1	6.33	1.47	0.00	0.00	0.45	0.34	0.23	0.00
Fibroblast - Dermal, donor5	11454-119A5	8.02	1.05	0.00	0.00	0.35	0.00	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	6.50	1.62	0.16	0.16	0.32	0.49	0.16	0.16
Fibroblast - Gingival, donor1	11237-116D4	7.08	3.12	0.00	0.21	0.21	0.21	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	17.03	2.36	1.31	0.26	0.00	0.26	0.26	0.26
Fibroblast - Gingival, donor2	11318-117D4	7.12	3.56	0.13	0.13	0.00	0.53	0.00	0.00
Fibroblast - Gingival, donor3	11394-118C8	8.41	2.42	0.19	0.19	0.00	0.48	0.10	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	23.89	8.31	3.12	0.00	0.00	1.04	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	20.97	10.75	1.59	1.06	0.70	0.00	0.00	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	9.67	1.25	0.31	0.31	0.16	0.31	0.47	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	9.33	1.35	0.00	0.14	0.41	0.27	0.14	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	36.35	7.06	0.71	0.00	1.41	1.41	0.35	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	14.19	1.90	0.73	0.15	0.29	0.00	0.00	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	11.45	2.45	0.95	0.27	0.41	0.14	0.41	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	14.04	3.07	1.65	0.11	0.33	0.44	0.33	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	29.93	5.28	1.17	0.73	0.59	0.59	0.29	0.29
Fibroblast - Lung, donor1	11270-116H1	4.08	0.00	0.00	1.36	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	2.98	1.49	0.00	0.00	0.00	0.00	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	4.64	0.84	0.21	0.00	0.21	0.00	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	10.83	0.00	0.00	0.00	0.83	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	4.20	1.40	0.00	0.00	0.00	0.00	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	7.84	1.40	0.00	0.00	0.00	0.00	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	15.02	2.44	0.41	0.81	0.41	0.00	0.41	0.41
Fibroblast - Mammary, donor2	11620-122A9	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	7.76	1.55	0.19	0.00	0.39	0.19	0.39	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	10.47	3.03	0.00	0.00	0.46	0.76	0.30	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	6.43	1.53	0.31	0.00	0.00	0.00	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	20.23	4.20	0.76	0.38	0.76	0.00	0.76	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	16.74	8.91	1.89	1.08	0.27	0.00	1.08	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	17.40	7.89	0.81	0.93	0.81	0.12	0.70	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	8.40	2.65	0.55	0.11	0.11	0.22	0.55	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	8.33	3.05	0.41	0.00	0.00	0.20	0.81	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	2.00	0.67	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	6.33	0.00	0.40	0.00	0.00	0.40	0.40	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	26.99	4.37	1.19	0.79	0.60	0.99	0.79	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	15.45	4.62	0.89	0.18	0.18	0.36	0.71	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	13.40	2.96	0.59	0.39	0.79	0.39	0.20	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	14.74	1.81	0.60	1.50	0.00	0.30	0.60	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	16.19	2.37	0.54	0.43	0.32	0.32	0.54	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	28.60	3.54	0.51	0.25	0.51	1.01	1.52	0.00
Fibroblast - skin normal, donor1	11553-120C5	13.62	3.12	1.80	0.33	0.16	0.16	0.49	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	16.64	3.01	1.80	0.40	1.00	0.60	1.00	0.00
Fibroblast - skin normal, donor2	11561-120D4	16.07	2.71	0.60	0.50	0.70	0.20	0.90	0.50
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	27.20	2.72	0.00	0.00	0.91	2.12	0.60	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	20.30	2.90	1.24	0.83	0.08	0.08	0.25	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	14.87	2.22	1.20	0.17	0.00	0.00	0.68	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	29.56	3.28	1.31	0.99	0.66	0.00	0.66	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	13.74	2.24	0.85	0.11	0.53	0.32	0.85	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	12.48	2.70	1.01	0.34	0.00	1.18	0.34	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	12.86	0.78	0.16	0.16	0.00	0.31	0.31	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	22.16	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	24.40	5.23	0.00	0.87	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	10.23	3.64	1.21	0.17	0.00	0.35	0.00	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	18.22	5.20	1.82	1.04	0.26	0.00	1.30	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	13.03	5.11	0.77	0.26	0.26	0.00	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	5.36	4.59	0.77	0.00	0.00	0.77	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	9.57	1.91	0.00	0.00	1.91	1.28	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	8.27	4.85	0.29	0.00	1.71	0.86	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	7.72	3.86	0.00	0.00	2.76	2.21	0.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	9.82	5.25	0.23	0.91	0.68	1.37	0.23	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	6.74	3.17	0.59	0.40	2.18	0.99	0.20	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	9.25	2.91	0.53	0.00	2.64	2.38	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	10.76	5.54	0.33	0.00	1.30	1.63	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	4.42	2.65	0.44	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	4.80	3.39	0.14	0.00	0.85	0.71	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	8.13	4.56	0.37	0.00	0.99	0.99	0.25	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	6.98	2.69	0.00	0.00	0.54	0.54	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	10.65	4.58	0.00	0.37	1.24	0.50	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	8.58	7.20	0.42	0.42	1.11	0.55	0.00	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	8.74	4.88	0.81	0.20	1.22	0.81	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	10.04	3.65	0.68	0.00	1.37	1.14	0.00	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	9.59	7.72	0.12	0.50	1.37	0.75	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	11.58	7.43	1.09	0.22	0.87	1.31	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	10.64	2.95	0.89	0.00	0.00	0.89	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	11.29	4.13	0.00	0.00	0.48	0.79	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	7.60	3.35	0.67	0.00	1.56	0.45	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	13.91	4.03	1.21	0.00	0.60	0.81	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	14.08	5.43	0.85	0.34	0.00	1.53	0.34	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	15.16	9.49	0.80	0.00	1.33	0.62	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	13.22	7.80	1.56	0.10	0.73	0.52	0.62	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	12.13	4.27	1.02	0.00	0.85	0.85	0.34	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	12.06	3.32	0.33	0.22	1.11	1.00	0.22	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	11.56	5.49	0.58	0.17	0.92	0.92	0.25	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	8.78	3.27	1.43	0.00	1.23	0.82	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	12.58	5.16	0.83	0.00	0.62	0.83	0.62	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	12.91	3.34	0.58	0.00	1.15	0.46	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	17.18	4.50	0.33	0.00	0.67	1.00	0.33	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	13.01	2.87	0.66	0.00	0.88	1.10	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	15.01	5.29	0.74	0.37	0.61	0.74	0.12	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	15.40	3.57	0.49	0.16	0.49	1.46	0.65	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	12.51	3.53	1.92	0.64	0.32	1.28	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	13.74	5.12	0.66	0.38	0.57	0.95	0.38	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	13.13	3.16	0.63	0.32	1.58	0.63	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	11.56	4.26	0.61	0.00	0.61	0.30	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	13.90	3.24	0.63	0.10	0.94	1.57	0.52	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	7.68	2.85	0.22	0.22	0.66	0.66	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	12.34	4.49	0.28	0.56	0.56	0.56	0.56	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	13.89	6.11	0.74	0.28	0.46	0.56	0.19	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	10.96	2.14	0.00	0.27	0.00	0.27	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	12.85	6.43	0.77	0.15	0.46	0.46	0.46	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	12.05	4.92	0.39	0.52	0.52	0.26	0.52	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	8.67	3.25	0.54	0.81	0.00	0.81	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	19.91	3.13	1.47	0.74	0.74	0.18	0.74	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	17.76	4.82	1.97	0.00	0.44	0.44	0.88	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	17.85	5.95	0.99	0.00	0.00	0.00	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	18.20	4.88	1.19	0.40	0.79	0.13	0.26	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	11.50	2.62	1.61	0.20	0.20	0.40	0.81	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	15.50	7.88	0.76	0.51	0.25	0.25	0.51	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	3.38	3.98	0.20	0.00	1.00	0.80	0.00	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	7.09	3.39	0.00	0.00	0.46	1.69	0.00	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	4.30	3.07	0.00	0.00	0.61	0.61	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	2.82	1.25	0.31	0.00	0.63	0.31	0.00	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	1.13	1.41	0.28	0.00	0.57	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	5.07	2.31	0.46	0.00	1.84	0.46	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	2.47	7.42	0.00	0.00	2.47	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	8.51	3.09	0.77	0.00	1.16	1.16	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	6.42	3.21	1.60	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	5.22	0.00	1.74	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	4.56	1.30	0.00	0.00	0.65	0.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	7.82	3.29	0.82	0.00	0.00	0.41	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	13.33	3.33	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	5.87	2.80	0.00	0.00	0.84	1.40	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	5.88	2.61	0.00	0.33	0.98	0.33	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	5.87	3.36	0.00	0.00	1.68	0.84	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	7.95	4.77	0.32	0.00	1.59	0.95	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	5.43	3.06	0.00	0.00	0.34	0.34	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	4.18	4.18	0.00	0.00	0.00	4.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	4.01	1.72	0.00	0.00	0.57	1.15	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	2.66	2.07	0.30	0.00	0.89	1.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	6.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	7.04	2.90	0.41	0.00	0.00	1.24	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	8.74	4.83	0.46	0.00	2.07	1.38	0.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	5.27	10.54	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	6.92	1.92	0.00	0.38	0.38	0.38	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	5.87	2.28	0.33	0.00	0.00	0.98	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	8.03	3.34	1.34	0.00	1.34	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	10.79	1.54	0.39	0.00	0.39	0.00	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	12.32	2.74	0.68	0.34	1.71	0.34	0.34	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	9.94	0.00	0.00	0.00	4.97	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	8.97	2.83	0.47	0.00	0.94	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	5.43	3.02	0.00	0.00	0.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	8.65	4.07	1.02	0.51	0.51	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	6.78	2.39	0.80	0.00	0.00	1.20	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	7.89	2.96	1.48	0.00	0.99	0.99	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	4.72	3.54	1.18	0.00	1.18	1.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	2.92	4.08	0.58	0.00	0.58	1.17	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	7.02	1.32	1.32	0.00	1.32	1.32	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	6.78	3.39	0.00	0.00	0.85	0.85	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	11.94	2.98	0.60	0.60	0.00	0.60	1.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	9.70	1.46	0.49	0.49	3.40	0.49	0.49	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	4.57	0.00	3.42	0.00	0.00	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	9.15	6.24	0.00	0.42	0.00	0.00	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	7.87	2.25	1.12	0.00	1.12	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	9.83	1.59	0.63	0.32	0.00	0.00	0.95	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	5.01	0.42	0.00	0.00	0.00	0.42	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	4.87	0.93	0.12	0.00	0.00	0.12	0.00	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	4.39	1.01	0.00	0.00	0.34	0.34	0.17	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	5.69	0.91	0.00	0.00	0.23	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	5.14	0.66	0.11	0.00	0.33	0.33	0.55	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	3.44	0.43	0.21	0.21	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	3.23	0.86	0.00	0.00	0.00	0.22	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	3.61	1.00	0.00	0.12	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	4.46	0.34	0.34	0.17	0.00	0.34	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	3.20	0.32	0.00	0.00	0.00	0.64	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	11.19	6.72	0.00	0.00	0.00	0.56	1.12	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	12.12	4.33	0.87	0.43	0.43	0.43	0.87	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	29.08	0.00	0.00	0.00	0.00	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	8.82	1.41	0.71	0.00	1.06	0.35	0.35	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	6.54	1.45	0.73	0.00	0.00	0.73	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	5.25	1.57	0.17	0.00	0.00	0.52	0.00	0.17
Hepatocyte, donor1	11523-119I2	15.74	9.68	1.21	1.21	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	17.24	5.39	1.08	1.08	0.00	1.08	1.08	0.00
Hepatocyte, donor3	11684-122I1	21.47	2.45	0.00	1.23	0.61	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	14.36	0.65	0.65	0.65	0.00	1.96	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	11.54	4.54	0.35	0.52	0.00	1.05	0.00	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	6.72	2.47	0.96	0.27	0.41	0.82	0.41	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00	6.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	8.31	0.00	0.00	0.00	1.38	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2.50	0.00	0.00	0.00	0.00	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	7.69	0.00	0.00	0.00	2.56	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	9.14	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	11.37	1.62	0.00	0.00	1.62	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	8.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	3.63	0.00	0.00	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	21.18	2.65	0.00	0.00	1.32	1.32	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	8.87	1.11	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	10.71	1.89	0.00	0.00	0.63	1.26	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	3.09	0.00	0.00	0.00	0.00	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	9.04	3.88	0.00	0.00	0.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	9.66	6.44	1.61	0.00	3.22	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	11.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	7.33	7.33	0.00	0.00	0.81	0.00	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	5.04	2.10	0.42	0.00	0.84	0.00	0.84	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	14.47	0.80	0.00	0.00	0.80	2.41	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	10.16	0.00	0.92	0.00	0.00	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	3.78	0.94	0.00	0.00	0.00	0.47	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	0.91	3.63	1.81	0.00	0.00	0.00	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00	0.00	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	8.61	1.08	2.15	0.00	2.15	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	5.08	1.27	1.27	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	10.20	0.64	0.64	0.00	0.00	2.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	5.47	1.82	0.00	0.00	3.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	10.00	1.43	0.71	0.00	2.86	0.00	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	9.95	6.64	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	6.79	0.93	0.00	0.62	1.23	0.93	0.62	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	7.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	6.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	4.17	4.87	0.00	0.00	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	13.28	11.07	2.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	13.95	3.49	0.00	0.00	2.62	3.49	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	15.75	2.25	0.00	2.25	0.00	2.25	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	10.45	10.45	0.00	3.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	17.07	6.40	0.00	1.07	0.00	0.00	2.13	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	15.24	4.16	0.00	0.00	1.39	0.00	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	2.85	0.00	0.00	0.00	2.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	8.28	3.68	0.00	0.00	0.00	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	12.10	0.00	0.00	0.00	0.00	0.00	0.00	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	6.21	0.00	0.00	6.21	6.21	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	10.57	5.29	0.00	1.06	2.11	2.11	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	11.91	0.98	0.41	0.08	0.16	0.33	0.33	0.00
Keratinocyte - epidermal, donor2	11349-117G8	8.20	0.59	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	6.25	0.47	0.19	0.28	0.09	0.28	0.00	0.00
Keratinocyte - oral, donor1	11251-116E9	17.25	0.91	0.23	0.11	0.45	0.34	0.68	0.00
Keratocytes, donor1	11527-119I6	9.28	3.09	0.00	0.00	0.69	0.34	0.00	0.00
Keratocytes, donor2	11607-120I5	2.34	3.52	0.00	0.00	1.17	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	7.90	1.38	0.40	0.40	0.00	0.00	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	17.58	10.99	4.40	2.20	0.00	0.00	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	7.55	5.39	1.08	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	7.15	3.58	1.04	0.00	0.00	0.58	0.23	0.35
Lens Epithelial Cells, donor3	11690-122I7	12.92	4.04	2.22	0.20	0.81	0.10	0.91	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	11.86	15.77	1.66	0.59	0.59	0.36	0.47	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	7.81	5.86	0.56	0.28	0.00	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	10.86	12.12	1.10	0.16	0.31	0.00	0.79	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	8.60	8.07	0.00	0.00	0.54	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	8.51	5.67	0.00	0.32	0.32	0.32	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	7.65	7.55	1.29	0.22	0.11	0.22	0.11	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	12.72	6.98	0.41	0.41	0.00	0.41	0.41	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	9.61	6.83	0.51	0.00	0.25	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	9.15	10.13	1.55	0.84	0.14	0.28	0.84	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	7.12	8.31	0.79	0.00	0.79	0.40	0.79	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	10.08	8.92	0.58	0.39	0.97	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	4.07	6.48	0.37	0.19	0.19	0.19	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	5.92	9.41	0.35	0.70	0.35	0.70	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	8.59	8.35	0.95	0.24	0.48	0.00	0.48	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	9.20	7.69	0.82	0.55	0.82	0.14	0.82	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	7.39	9.85	0.62	0.00	0.31	0.00	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	8.73	4.05	0.31	0.00	0.00	0.00	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	7.69	8.97	0.73	0.55	0.37	0.18	0.55	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	9.22	10.20	1.97	0.33	0.66	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	4.98	5.86	0.59	0.00	0.88	0.29	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	7.47	7.72	0.75	0.00	0.00	0.00	0.25	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	10.67	6.30	0.48	0.48	0.00	0.48	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	12.93	6.19	0.54	0.27	0.81	0.54	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	7.27	7.87	1.51	0.61	0.45	0.30	0.76	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	7.26	8.29	0.52	0.00	1.04	1.04	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	14.87	8.79	1.26	0.84	1.05	0.84	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	7.22	7.52	1.20	0.15	0.30	0.15	0.45	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	15.82	6.19	0.69	0.00	1.38	0.00	0.00	2.06
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	10.35	5.27	1.32	0.19	0.38	0.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	7.10	7.63	0.95	0.42	0.53	0.21	0.74	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	10.66	6.78	0.97	0.48	0.97	0.48	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	7.61	5.62	0.33	0.00	0.66	0.00	0.66	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	9.04	8.42	0.99	0.25	0.37	0.00	0.50	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	15.55	8.51	1.11	0.74	0.00	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	8.89	4.45	0.74	0.00	0.49	0.49	0.00	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	7.56	5.91	0.96	0.00	0.41	0.14	0.69	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	11.26	10.61	0.96	0.64	1.29	0.00	0.64	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	16.43	8.52	0.61	0.00	0.61	0.91	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	11.76	10.64	1.82	0.28	0.28	0.28	0.42	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	7.82	6.40	0.36	0.71	0.36	0.36	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	12.12	5.33	1.45	0.00	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	8.56	7.31	0.62	0.16	0.62	0.31	0.31	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	9.31	10.03	0.36	1.43	0.00	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	7.51	5.23	1.63	0.33	0.33	0.33	0.65	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	6.36	5.41	1.18	0.24	0.00	0.00	0.47	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	8.54	10.89	1.49	0.37	0.99	0.25	0.74	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	9.22	4.87	0.26	0.26	0.51	0.26	0.77	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	8.95	12.83	0.30	0.60	0.90	0.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	15.86	2.27	0.00	0.00	4.53	0.00	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	7.67	0.77	0.77	0.77	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	5.20	0.00	0.00	0.74	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	8.46	1.27	0.00	0.42	0.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	4.92	1.41	0.70	1.41	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	3.74	0.00	0.00	0.00	0.93	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	5.67	0.52	0.00	0.00	0.00	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	4.76	1.19	1.19	1.19	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	6.11	0.68	0.23	0.23	0.23	0.90	0.68	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	3.78	0.87	0.29	0.29	0.00	0.00	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	4.50	0.90	0.00	0.00	0.00	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	8.81	1.35	0.27	0.27	0.27	0.54	0.14	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	3.59	1.03	1.03	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	5.29	1.76	0.00	0.00	0.00	1.06	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	3.33	1.33	0.00	0.00	0.00	1.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	4.08	1.02	0.00	0.00	0.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	6.14	1.60	0.00	0.53	0.27	0.27	0.00	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	5.86	1.32	0.38	0.19	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	7.36	0.61	0.00	0.00	1.23	1.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	10.60	0.82	0.00	0.82	0.82	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	5.83	0.62	0.21	0.42	0.21	0.83	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	4.48	0.00	0.00	0.00	0.56	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	6.18	1.03	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	4.06	2.03	0.00	0.29	0.00	0.58	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	3.89	0.90	0.30	0.30	0.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	3.87	0.55	0.55	0.55	0.55	0.55	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	7.07	1.77	0.00	0.00	0.35	0.35	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	4.43	1.11	0.00	0.00	0.37	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	4.61	2.30	0.00	0.00	0.00	0.00	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	5.37	2.30	0.00	0.38	1.15	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	10.19	0.57	0.57	1.13	0.57	0.00	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	4.92	0.82	0.00	0.82	0.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	9.04	2.26	0.00	0.00	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	5.75	0.72	0.00	0.00	0.00	3.59	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	5.98	0.75	0.00	0.75	0.75	0.75	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	4.09	2.23	0.37	0.00	1.11	0.37	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	4.74	0.86	0.00	0.43	0.43	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	5.14	1.71	0.00	0.00	0.86	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	8.66	1.00	0.67	0.33	0.00	1.33	0.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	6.03	0.60	0.00	0.60	0.60	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	2.84	2.13	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	5.16	0.34	0.34	0.00	1.03	0.00	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	6.98	3.22	0.00	0.00	0.00	0.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	8.08	1.35	1.35	0.00	0.67	2.69	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	6.30	2.59	0.74	0.37	1.11	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	8.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	2.12	0.00	0.00	0.00	1.06	1.06	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	10.00	0.80	0.80	0.00	1.20	0.80	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	5.09	2.91	0.00	0.00	0.73	0.73	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	11.50	2.30	0.77	0.00	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	9.37	1.97	0.00	0.49	0.49	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	3.76	0.94	0.94	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	6.54	1.51	0.00	0.00	1.51	0.50	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	7.66	0.45	0.00	0.00	0.45	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	8.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	7.57	0.89	0.00	0.89	0.00	1.78	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	8.21	0.78	1.17	0.00	1.96	0.39	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	6.60	1.98	0.00	0.00	1.32	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	5.19	0.00	0.00	0.00	2.08	1.56	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	10.94	0.44	0.44	0.44	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	5.03	1.68	0.00	0.00	1.12	0.56	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	5.30	0.88	0.00	0.00	0.88	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	6.17	1.16	0.39	0.00	0.39	0.77	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	3.04	1.52	1.52	0.00	1.52	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	8.65	0.48	0.00	0.48	0.48	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	8.35	0.80	0.40	0.00	0.40	0.40	0.40	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	5.47	3.65	0.00	0.00	0.00	0.61	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	4.84	0.00	0.00	0.00	0.69	1.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	6.08	1.52	0.38	0.76	1.52	0.76	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	4.65	1.03	0.00	0.00	0.00	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	6.05	1.21	0.60	0.00	0.60	0.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	9.51	0.95	0.00	0.00	0.00	1.27	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	8.53	1.60	1.07	0.53	0.00	0.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	8.62	0.57	0.00	1.72	0.57	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	8.23	0.51	0.00	1.54	1.03	1.54	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	7.07	1.41	1.41	0.00	0.71	0.71	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	4.54	0.57	0.00	0.00	1.13	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	9.15	1.66	0.83	0.00	0.83	0.83	0.83	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	4.70	1.57	0.00	0.00	0.78	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	5.43	0.84	0.42	0.00	0.84	1.67	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	5.58	0.46	0.93	0.46	0.00	0.46	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	5.35	2.01	1.34	0.00	0.67	1.34	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	4.81	1.60	0.00	0.00	1.07	0.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	6.47	2.83	0.00	0.40	1.21	0.81	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	5.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	3.56	1.78	0.00	0.89	1.78	1.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	11.97	1.71	0.57	0.00	0.57	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	8.44	3.07	0.00	0.00	0.77	1.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	5.47	3.28	0.00	0.00	0.55	1.64	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	4.90	1.34	0.45	0.45	0.00	0.45	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	6.24	1.56	0.52	0.26	0.52	0.52	0.52	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	4.64	1.33	0.00	0.00	1.33	1.33	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	0.00	4.16	0.00	0.00	2.08	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	21.42	18.23	2.28	0.00	0.68	0.23	0.46	0.00
Macrophage - monocyte derived, donor2	11313-117C8	12.66	12.85	5.51	0.37	1.28	0.73	2.20	0.18
Macrophage - monocyte derived, donor3	11389-118C3	23.07	15.60	1.70	1.44	0.79	0.39	0.79	0.39
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	9.56	1.59	1.06	0.53	0.00	0.00	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	16.32	3.64	2.06	0.32	0.48	0.16	0.63	0.16
Mallassez-derived cells, donor3	11930-125I4	13.76	2.22	1.53	0.56	0.14	0.42	0.69	0.14
Mammary Epithelial Cell, donor1	11273-116H4	17.04	1.20	0.50	0.60	0.10	0.30	0.30	0.00
Mammary Epithelial Cell, donor2	11350-117G9	11.87	1.74	0.00	0.58	0.58	0.29	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	9.23	1.75	0.25	0.25	0.00	0.00	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	28.47	34.57	14.24	1.36	1.36	0.00	2.71	6.78
Mast cell, donor1	11563-120D6	49.74	22.60	5.84	1.84	3.46	1.51	3.89	1.19
Mast cell, donor2	11565-120D8	94.80	19.91	5.94	3.86	3.57	3.57	5.94	1.49
Mast cell, donor3	11566-120D9	135.75	28.59	6.08	4.05	4.28	8.10	4.73	1.80
Mast cell, donor4	11567-120E1	68.26	8.86	3.19	1.60	1.24	1.42	2.30	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	62.88	11.53	6.88	1.00	4.10	2.99	2.88	0.78
Mast cell, expanded and stimulated, donor8	11942-126A7	46.69	7.59	2.92	0.00	4.67	1.75	2.33	0.58
Mast cell, expanded, donor5	11939-126A4	64.47	14.45	3.79	1.26	3.33	2.98	1.95	0.46
Mast cell, expanded, donor8	11941-126A6	64.77	11.05	2.34	1.17	2.68	3.85	0.33	0.84
Melanocyte - dark, donor1	11502-119F8	8.66	8.95	1.19	0.20	0.60	0.20	0.90	0.40
Melanocyte - dark, donor2	11582-120F7	6.23	1.73	0.69	0.35	0.00	0.00	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	10.36	2.54	0.51	0.65	0.00	0.14	0.29	0.00
Melanocyte - light, donor1	11274-116H5	11.05	1.65	0.94	0.00	0.00	0.00	0.47	0.00
Melanocyte - light, donor2	11351-117H1	6.82	2.05	0.00	0.00	0.68	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	6.07	3.47	0.87	0.87	0.00	0.87	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	10.83	3.02	0.62	0.73	0.21	0.52	0.31	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	6.99	1.88	0.27	0.00	0.54	0.54	0.54	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	17.41	1.87	0.80	1.34	0.54	0.00	0.27	0.00
Meningeal Cells, donor1	11493-119E8	12.03	5.83	1.61	0.12	0.62	0.74	0.62	0.12
Meningeal Cells, donor2	11573-120E7	3.96	6.16	0.00	0.00	0.00	0.00	0.88	0.44
Meningeal Cells, donor3	11654-122E7	8.64	3.91	1.87	0.08	1.06	0.49	0.33	0.73
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	5.13	2.28	0.29	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	22.04	5.94	2.92	0.20	0.60	0.20	0.60	1.01
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	10.51	0.00	0.00	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	5.23	0.00	1.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	8.61	2.15	0.00	0.00	0.72	1.44	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	9.11	3.18	1.91	0.21	0.21	0.00	1.69	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	4.02	1.01	0.50	0.00	1.01	0.00	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	6.59	3.08	1.32	0.00	0.66	0.22	0.88	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	5.11	2.19	0.00	0.00	1.46	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	7.37	1.84	0.20	0.41	0.20	0.61	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	6.65	1.94	0.28	0.14	0.28	0.14	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	5.20	1.86	0.00	0.00	0.00	0.37	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	8.42	2.89	0.53	0.39	0.26	0.00	0.13	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	4.15	1.19	0.00	0.30	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	10.25	2.56	0.00	0.00	0.64	0.64	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	6.38	2.13	0.35	0.35	0.35	0.35	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	8.44	2.50	0.63	0.31	0.00	0.00	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	8.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	6.36	2.39	0.27	0.27	0.27	0.27	0.27	0.27
Mesothelial Cells, donor2	12156-128G5	5.51	1.50	1.00	0.00	0.50	0.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	7.08	3.04	0.72	0.07	0.36	0.07	0.51	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	14.85	14.85	2.70	1.35	1.35	0.00	4.05	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	15.27	8.62	2.46	1.23	0.49	0.49	0.25	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	10.31	7.66	1.47	0.00	1.47	0.00	0.29	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	6.91	3.46	0.00	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	9.61	6.51	1.55	0.31	0.62	0.00	0.31	0.93
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	7.47	7.26	2.07	0.21	0.83	0.00	0.62	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	11.58	13.90	2.32	0.00	0.00	0.00	0.00	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	16.77	4.75	2.50	0.75	0.25	0.25	1.50	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	11.64	6.52	4.19	0.47	1.40	0.93	0.00	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	19.47	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	8.74	6.10	1.42	0.81	0.41	0.20	1.22	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	9.11	7.13	0.40	0.40	1.19	0.40	1.19	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	8.55	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	5.31	5.31	0.00	0.00	1.77	0.00	0.00	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	6.84	4.18	2.28	0.38	0.76	0.38	0.76	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	9.21	6.58	0.00	0.00	0.00	0.00	0.00	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	14.01	7.64	1.70	0.42	0.42	0.42	0.64	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	5.52	4.60	0.00	0.92	0.00	0.92	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	12.82	3.87	2.09	0.60	1.19	0.30	1.79	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	6.71	8.38	3.35	3.35	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	10.29	5.02	2.01	0.75	0.00	0.25	1.00	0.75
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	9.27	6.65	1.43	0.24	0.48	0.48	0.48	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	10.50	11.61	1.11	0.00	0.55	0.00	1.11	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	10.59	8.52	1.61	1.84	0.23	0.23	0.92	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	12.41	6.10	2.31	0.21	1.26	0.21	1.05	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	9.17	11.82	2.45	1.02	0.61	0.20	0.61	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	10.73	5.36	1.50	0.43	0.64	0.00	0.64	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	6.67	7.11	1.78	0.44	0.22	0.00	0.67	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	10.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	7.88	10.07	2.19	0.44	0.00	0.00	0.88	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	7.10	11.15	1.52	0.00	0.00	0.00	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	11.60	14.91	1.66	0.00	0.00	0.00	0.00	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	14.40	13.59	3.53	0.82	0.54	0.00	1.36	0.82
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	9.12	14.12	3.23	0.00	0.59	0.29	1.18	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	7.63	20.72	3.27	1.09	0.00	0.00	1.09	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	6.25	22.11	2.40	1.44	0.48	0.48	0.96	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	10.81	22.01	2.80	0.40	0.40	0.80	1.60	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	5.48	20.57	1.37	1.37	0.00	0.00	0.00	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	7.01	28.53	5.01	1.00	0.00	0.00	1.00	1.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	26.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	14.27	2.04	2.04	0.00	0.00	4.08	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	5.69	23.21	7.01	2.19	0.00	0.00	3.07	1.31
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	7.73	7.73	2.21	1.10	0.00	1.10	2.21	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	7.04	39.06	3.84	3.20	0.64	0.00	2.56	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	7.19	23.55	4.21	1.74	0.00	0.00	2.48	0.99
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	7.65	11.13	2.78	0.70	0.00	0.00	2.78	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	4.42	13.26	2.21	4.42	0.00	0.00	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	7.18	21.20	4.44	2.05	0.00	0.00	1.03	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	4.81	17.50	0.88	0.44	0.44	0.00	1.75	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	11.01	30.54	0.71	5.33	0.00	0.00	0.71	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	7.01	20.20	5.05	0.84	0.00	0.00	0.56	1.96
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	7.07	10.81	1.66	2.91	0.42	0.00	2.08	1.25
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	6.99	24.48	1.17	5.24	0.00	0.00	1.17	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	8.14	29.56	3.02	2.41	0.00	0.00	2.11	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	6.26	14.19	0.83	0.83	0.00	0.42	1.25	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	21.66	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	6.46	19.39	2.77	1.85	0.00	0.92	1.85	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	5.12	13.66	1.71	2.28	0.00	0.00	0.57	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	9.81	21.83	1.11	2.07	0.00	0.14	1.11	0.41
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	9.33	19.70	1.81	1.81	0.00	0.00	1.30	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	7.72	9.01	1.72	1.72	0.43	0.00	1.72	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	10.16	21.60	1.27	3.18	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	12.01	21.35	0.53	2.14	0.00	0.00	0.27	1.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	13.77	14.67	2.99	2.39	0.60	0.00	0.60	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	11.30	17.09	1.55	1.84	0.14	0.28	0.85	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	7.01	12.10	1.27	2.23	0.00	0.00	0.64	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	7.30	16.14	1.11	1.99	0.22	0.44	1.11	0.66
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	14.41	18.20	1.14	4.17	0.00	0.38	0.76	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	12.78	16.48	3.13	2.56	0.28	0.00	2.27	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	8.36	19.91	0.98	0.74	0.49	0.25	0.98	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	13.69	14.99	2.61	1.30	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	16.76	12.06	1.18	2.06	0.00	0.00	0.59	1.18
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	13.26	17.01	2.31	2.59	0.58	0.29	0.58	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	30.50	15.25	3.30	1.24	0.41	0.82	0.41	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	18.76	12.51	2.08	3.87	0.30	0.30	0.30	0.89
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	3.77	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	8.91	3.56	1.78	1.78	1.78	0.00	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	18.07	6.24	2.30	1.31	0.33	0.33	0.00	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	8.42	6.31	1.05	1.05	1.05	0.00	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	14.04	7.12	2.37	0.40	0.79	0.20	0.99	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	18.63	6.52	3.73	0.00	0.00	1.86	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	15.02	7.89	1.88	3.38	0.38	0.75	0.75	1.50
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	6.39	5.33	2.13	0.80	0.80	0.00	0.53	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	14.48	8.82	1.81	1.36	0.23	0.11	0.11	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	8.10	7.37	2.21	0.00	0.00	0.00	0.00	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	15.02	10.63	1.10	0.73	0.37	0.00	0.73	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	21.78	9.33	1.56	0.00	1.56	0.00	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	18.71	9.62	2.14	2.14	0.53	1.07	1.07	1.60
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	7.73	7.73	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	13.13	13.13	0.00	1.01	0.00	1.01	3.03	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	10.96	5.90	3.79	2.11	0.84	0.00	2.95	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	10.90	16.34	2.72	1.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	5.72	2.54	0.64	1.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	4.05	10.53	0.81	0.00	0.00	0.00	0.00	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	13.59	7.55	4.53	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	102.78	45.68	11.42	0.00	0.00	0.00	11.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	19.57	16.31	3.26	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	28.51	4.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	12.55	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	8.40	4.74	0.86	0.22	1.29	0.22	0.86	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	7.32	2.09	1.05	0.00	1.05	0.00	0.52	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	6.01	0.67	0.67	0.00	0.00	0.00	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	2.50	2.09	0.00	0.00	0.00	0.42	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	11.22	1.14	0.38	0.38	0.57	0.00	0.38	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	11.17	3.19	0.00	1.60	0.00	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	4.08	0.00	1.36	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	14.70	3.68	0.00	0.00	1.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	6.28	0.00	0.00	0.00	0.00	0.00	0.42	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	3.72	1.63	0.00	0.00	0.23	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	7.57	1.89	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	8.83	1.89	0.84	0.21	0.21	0.84	0.42	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	11.13	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	4.96	0.50	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	17.86	0.54	1.62	0.00	0.00	0.27	0.27	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	5.44	0.23	0.23	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	5.55	1.63	0.33	0.00	0.16	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	13.49	2.19	0.55	0.73	0.18	0.18	0.36	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	6.37	0.53	1.06	0.00	0.00	0.53	0.00	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	6.60	0.60	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	22.97	0.98	0.66	0.33	0.00	0.98	0.33	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	9.27	0.98	0.33	0.81	0.33	0.16	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	16.58	3.17	0.53	0.35	0.18	0.18	0.53	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	7.74	0.70	0.00	0.00	0.00	0.00	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	12.41	0.92	0.00	0.00	0.46	0.46	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	8.35	1.29	0.00	0.64	0.00	0.00	0.32	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	21.04	0.69	1.03	0.69	0.34	0.34	1.03	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	42.98	15.17	10.11	0.00	2.53	2.53	5.06	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	14.48	3.34	0.45	0.00	0.45	0.22	0.45	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	8.89	0.85	0.00	0.00	0.85	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	14.95	1.19	0.24	0.00	0.24	0.00	0.24	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	8.16	0.86	0.86	0.00	0.00	0.00	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	54.17	18.06	9.03	0.00	0.00	9.03	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	4.33	1.67	1.00	0.33	0.33	0.67	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	12.62	2.25	0.90	0.90	0.45	0.00	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	6.35	1.59	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	6.50	0.93	0.00	0.93	0.00	0.00	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	14.00	1.14	0.00	0.76	0.00	0.00	0.38	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	8.47	1.63	0.33	0.00	0.33	0.33	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	8.28	1.74	0.87	0.00	0.00	0.00	1.31	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	14.02	3.62	0.00	0.00	0.00	0.00	0.90	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.06	0.00	0.00	0.88	0.00	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	9.31	0.66	0.00	0.66	0.00	0.00	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	6.45	0.99	0.00	0.50	1.49	0.00	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	5.36	2.30	0.77	0.00	0.00	0.00	0.38	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	18.45	1.21	0.91	0.30	0.00	0.60	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	12.60	1.77	1.55	0.44	0.66	0.22	0.44	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	12.88	0.68	0.00	0.00	0.00	0.00	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	30.66	15.33	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	7.32	1.83	0.00	0.00	0.00	0.00	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	9.44	1.26	1.26	0.31	0.00	0.31	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	7.57	1.51	0.00	0.00	0.30	0.00	0.00	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	16.61	0.79	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	34.01	1.13	4.53	0.00	0.00	0.00	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	0.00	0.00	0.00	10.12	0.00	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	2.48	0.62	0.37	0.12	0.12	0.37	0.12	0.00
Myoblast, donor2	11322-117D8	6.14	1.15	0.96	0.38	0.19	0.19	0.19	0.00
Myoblast, donor3	11398-118D3	4.88	0.84	0.17	0.00	0.34	0.00	0.67	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	9.92	2.33	0.15	0.73	0.15	0.00	0.44	0.15
Natural Killer Cells, donor1	11230-116C6	33.52	18.45	2.15	2.15	0.92	0.92	0.92	0.62
Natural Killer Cells, donor2	11311-117C6	35.28	10.25	1.81	3.32	0.30	1.51	0.90	0.00
Natural Killer Cells, donor3	11387-118C1	31.29	17.85	1.84	2.21	0.92	0.74	1.10	0.37
Neural stem cells, donor1	11275-116H6	22.87	9.44	5.08	0.00	1.81	1.09	2.18	1.09
Neural stem cells, donor2	11352-117H2	15.41	9.63	0.00	0.00	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	12.52	3.41	1.14	0.00	1.14	0.00	0.00	0.00
Neurons, donor2	11574-120E8	10.57	3.74	1.54	0.44	0.44	1.10	0.66	0.00
Neurons, donor3	11655-122E8	7.40	0.82	1.64	0.82	0.00	0.00	0.00	0.00
Neutrophils, donor1	11233-116C9	68.67	116.93	9.28	8.35	1.86	1.86	0.00	0.00
Neutrophils, donor2	11314-117C9	69.57	92.76	5.80	2.90	5.80	0.00	2.90	0.00
Neutrophils, donor3	11390-118C4	111.78	145.38	14.05	26.88	1.22	1.83	3.67	1.83
Nucleus Pulposus Cell, donor1	11252-116F1	9.74	3.21	0.83	0.71	0.24	0.36	0.71	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	5.21	1.63	0.33	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	3.41	2.81	0.20	0.00	0.00	0.00	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	8.67	2.34	1.10	0.41	0.41	0.14	0.41	0.41
Olfactory epithelial cells, donor2	11934-125I8	9.84	2.17	0.72	0.58	0.29	0.00	0.58	0.43
Olfactory epithelial cells, donor3	11935-125I9	10.22	1.82	0.79	0.34	0.11	0.34	0.23	0.57
Olfactory epithelial cells, donor4	11936-126A1	17.92	3.60	0.88	0.29	0.49	0.39	0.58	0.39
Oligodendrocyte - precursors, donor1	11496-119F2	10.83	3.01	0.00	0.60	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	5.53	1.49	0.21	0.21	0.21	0.00	0.21	0.21
Osteoblast - differentiated, donor2	11353-117H3	8.00	1.14	0.00	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	6.83	1.86	0.00	0.00	0.00	0.00	0.62	0.00
Osteoblast, donor1	11277-116H8	8.21	2.15	1.56	0.00	0.59	0.59	1.37	0.00
Osteoblast, donor2	11354-117H4	15.45	3.51	1.40	0.70	0.00	0.70	0.00	0.70
Osteoblast, donor3	11426-118G4	10.13	1.96	1.24	0.36	0.00	0.18	0.36	0.18
Pancreatic stromal cells, donor1	11249-116E7	8.93	1.10	0.42	0.17	0.25	0.17	0.17	0.00
Pericytes, donor1	11491-119E6	4.78	2.11	0.22	0.00	0.11	0.22	0.45	0.33
Pericytes, donor2	11571-120E5	3.62	2.49	0.45	0.23	0.68	0.91	0.45	0.45
Pericytes, donor3	11652-122E5	10.17	2.44	0.41	0.20	0.61	0.20	0.00	0.20
Perineurial Cells, donor1	11499-119F5	5.20	3.39	0.34	0.00	0.11	0.23	0.45	0.11
Perineurial Cells, donor2	11579-120F4	8.28	2.94	0.74	0.18	0.18	0.37	0.37	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	45.90	39.52	2.23	5.10	0.32	0.64	0.64	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	41.63	25.22	1.96	5.14	0.73	0.98	1.22	1.22
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	36.37	34.04	2.46	6.21	0.78	0.39	0.52	0.78
Placental Epithelial Cells, donor1	11278-116H9	3.11	0.48	0.00	0.00	0.00	0.24	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	3.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	2.36	0.79	0.20	0.00	0.20	0.20	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	11.39	1.27	0.32	0.00	0.00	0.00	0.00	0.32
Preadipocyte - breast, donor1	11467-119B9	9.38	1.13	0.38	0.00	0.38	0.19	0.19	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	21.01	4.05	1.83	0.39	0.26	0.13	1.57	0.26
Preadipocyte - breast, donor2	11328-117E5	11.48	2.70	0.68	0.45	0.00	0.45	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	7.57	1.07	0.11	0.32	0.11	0.32	0.21	0.00
Preadipocyte - omental, donor2	11329-117E6	15.28	3.93	0.87	0.00	0.87	0.00	0.87	0.00
Preadipocyte - omental, donor3	11403-118D8	13.90	3.29	1.00	0.29	0.57	0.14	0.43	0.14
Preadipocyte - perirenal, donor1	11469-119C2	7.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	9.52	1.54	3.38	0.31	0.00	0.00	1.23	0.92
Preadipocyte - subcutaneous, donor2	11356-117H6	8.68	2.48	0.18	0.18	0.00	0.35	0.53	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	7.83	2.04	1.53	0.17	0.34	0.34	0.34	0.00
Preadipocyte - visceral, donor1	11280-116I2	6.80	1.58	0.47	0.37	0.09	0.09	0.28	0.00
Preadipocyte - visceral, donor2	11357-117H7	4.14	2.76	0.00	0.00	0.00	0.00	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	6.27	1.25	0.10	0.21	0.10	0.21	0.10	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	7.69	3.92	0.30	0.30	0.91	0.75	0.30	0.00
Prostate Epithelial Cells, donor2	11331-117E8	10.56	2.57	0.95	0.81	0.41	0.00	0.27	0.27
Prostate Epithelial Cells, donor3	11404-118D9	17.09	0.86	0.00	0.31	0.06	0.37	0.00	0.00
Prostate Stromal Cells, donor1	11254-116F3	7.63	2.05	0.80	0.11	0.11	0.34	0.23	0.00
Prostate Stromal Cells, donor2	11332-117E9	5.02	1.79	0.36	0.18	0.18	0.18	0.36	0.00
Prostate Stromal Cells, donor3	11405-118E1	5.21	3.44	0.52	0.10	0.31	0.10	0.42	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	12.41	3.65	0.00	1.82	0.73	0.36	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	6.38	3.60	0.55	0.14	0.42	0.76	0.21	0.07
Renal Epithelial Cells, donor1	11517-119H5	10.65	7.61	0.51	0.51	0.00	0.51	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	14.94	4.98	0.00	1.42	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	14.19	6.25	0.95	0.21	1.27	0.64	0.74	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	5.45	8.85	0.00	1.36	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	8.62	4.18	0.40	0.67	0.40	0.27	0.13	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	19.54	5.99	0.44	0.00	0.67	0.67	0.67	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	6.65	5.32	1.33	0.00	0.00	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	6.60	5.28	0.88	0.22	0.88	0.44	0.22	0.22
Renal Mesangial Cells, donor2	11598-120H5	10.03	4.39	0.63	0.63	0.63	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	2.77	6.94	0.55	0.28	0.00	0.00	0.00	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	12.62	5.91	0.00	0.81	0.54	1.07	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	9.28	1.27	0.00	0.42	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	13.88	6.36	0.39	0.39	0.39	0.39	0.19	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	1.81	0.00	0.00	0.00	0.00	0.26	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	5.12	1.14	0.28	0.00	0.28	0.57	0.28	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	9.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	1.25	0.25	0.25	0.00	0.00	0.00	0.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	25.26	7.22	1.47	1.20	0.13	0.13	0.40	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	5.36	0.00	0.89	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	4.40	0.00	0.00	0.55	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	2.90	0.00	0.00	0.00	0.00	0.58	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	6.37	1.17	0.13	0.13	0.52	0.52	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	5.26	1.89	0.00	0.10	0.50	0.70	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	6.02	1.34	0.00	0.11	0.33	1.00	0.22	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	5.95	1.49	0.12	0.37	0.50	0.62	0.25	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	5.24	1.98	0.00	0.00	0.00	0.58	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	4.16	2.54	0.92	0.00	0.23	1.39	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	7.39	0.82	0.00	0.14	0.41	0.82	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	4.24	2.12	0.15	0.00	0.15	1.21	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	3.76	2.33	0.18	0.18	0.00	0.54	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	5.31	1.58	0.14	0.14	0.43	0.29	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	5.47	2.25	0.43	0.11	0.00	0.32	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	4.43	1.77	0.22	0.22	0.22	0.44	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	5.54	0.76	0.19	0.38	0.57	0.38	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	5.22	1.21	0.19	0.19	0.65	0.47	0.00	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	6.58	2.44	0.00	0.00	0.00	0.38	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	5.84	1.06	0.27	0.13	0.40	0.40	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	6.04	1.75	0.19	0.29	0.29	0.78	0.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	6.49	1.53	0.57	0.19	0.19	0.76	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	5.23	1.17	0.00	0.00	0.75	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	5.89	1.40	0.00	0.56	0.28	0.00	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	4.10	2.05	0.34	0.00	0.17	0.34	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	5.83	1.28	0.00	0.00	0.00	0.73	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	5.03	1.23	0.12	0.25	0.98	0.37	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	6.04	1.34	0.40	0.27	0.81	0.27	0.27	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	8.02	0.71	0.00	0.00	0.94	0.94	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	5.36	1.98	0.40	0.00	0.00	0.40	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	6.31	1.40	1.17	0.00	0.47	0.00	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	6.84	0.83	0.00	0.21	0.41	0.21	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	6.86	1.99	0.66	0.00	0.66	0.44	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	3.34	1.88	0.00	0.21	0.63	0.63	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	7.54	1.62	0.27	0.27	0.27	0.81	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	5.45	2.04	0.51	0.00	0.17	0.17	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	6.56	3.66	0.39	0.19	0.58	0.58	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	7.22	2.24	0.17	0.17	0.69	1.03	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	5.08	2.19	0.14	0.14	0.41	0.69	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	4.93	2.30	0.49	0.00	0.00	0.33	0.33	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	5.97	1.53	0.17	0.00	0.34	0.85	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	6.21	2.37	0.00	0.00	0.74	0.30	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	4.26	1.60	0.53	0.27	0.53	1.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	5.39	1.80	0.00	0.14	0.69	0.41	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	3.81	1.67	0.24	0.00	0.48	1.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	7.86	3.22	0.60	0.20	0.81	1.41	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	5.09	1.32	0.09	0.19	0.57	0.57	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	5.59	2.79	0.35	0.00	0.35	0.35	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	5.44	1.81	0.30	0.91	0.00	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	4.28	1.10	0.12	0.00	0.37	0.24	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	12.37	3.20	0.15	0.15	0.29	1.46	0.29	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	4.87	1.22	0.00	0.61	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	3.62	0.30	0.00	0.00	0.30	0.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	6.56	2.04	0.00	0.00	0.23	0.23	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	5.99	2.10	0.30	0.00	0.00	1.20	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	7.20	0.71	0.00	0.00	0.24	0.35	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	5.12	1.28	0.00	0.00	0.00	0.21	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	7.81	0.60	0.00	0.00	0.60	0.60	0.00	0.00
Schwann Cells, donor1	11498-119F4	5.64	1.88	0.38	0.00	0.38	0.00	0.19	0.00
Schwann Cells, donor2	11578-120F3	3.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	6.13	1.53	0.00	0.22	0.00	0.88	0.00	0.00
Sebocyte, donor1	11220-116B5	17.53	3.29	2.19	1.10	0.55	0.00	1.10	0.00
Sebocyte, donor2	11301-117B5	9.65	0.00	0.00	0.46	0.00	0.92	0.00	0.00
Sebocyte, donor3	11378-118B1	9.28	2.47	0.82	0.00	0.00	0.41	0.21	0.00
Sertoli Cells, donor1	11255-116F4	23.19	3.31	3.31	0.00	3.31	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	14.12	0.00	0.00	0.00	2.82	0.00	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	12.84	2.64	0.62	0.09	0.26	0.70	0.26	0.00
Skeletal Muscle Cells, donor2	11358-117H8	5.06	0.72	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	10.03	5.02	0.00	0.00	0.00	0.00	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	7.54	1.73	0.31	0.16	0.47	0.47	0.79	0.00
Skeletal Muscle Cells, donor5	11455-119A6	5.50	2.38	0.15	0.00	0.30	0.15	0.15	0.00
Skeletal Muscle Cells, donor6	11459-119B1	10.47	1.69	0.46	0.31	0.62	0.62	0.15	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	15.25	2.14	0.63	0.50	0.38	0.38	0.13	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	12.84	3.00	0.43	0.00	0.29	0.14	0.29	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	6.65	3.47	0.50	0.40	0.50	0.60	0.50	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	12.81	3.20	2.11	0.25	0.76	0.42	0.25	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	10.13	1.45	0.00	0.00	0.00	0.72	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	4.82	1.65	0.00	0.00	0.55	0.00	0.14	0.00
Skin - palm, donor1	10286-104F7	29.55	2.69	0.00	2.69	0.00	0.00	0.00	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	11.82	0.86	0.58	0.00	0.43	0.43	0.14	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	132.50	6.54	3.27	2.45	5.73	8.18	1.64	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	14.80	0.65	0.39	0.13	0.00	0.26	0.13	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	17.38	1.11	0.00	0.00	0.70	0.83	0.14	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	24.33	2.67	0.70	1.41	0.42	0.42	0.28	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	94.94	12.69	1.69	2.33	2.75	1.90	1.48	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	25.93	2.25	0.15	1.12	0.15	0.90	0.07	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	6.79	0.62	0.00	0.00	0.31	0.00	0.62	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	11.78	1.33	0.00	0.44	0.22	0.44	0.00	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	7.64	1.18	1.18	0.00	0.00	0.00	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	7.51	3.54	2.21	0.66	0.22	0.66	0.22	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	1.97	1.58	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	6.95	0.77	0.00	0.00	0.00	0.00	1.55	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	10.01	1.00	1.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	8.38	1.73	0.40	0.27	0.27	0.27	0.93	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	3.77	0.66	0.44	0.00	0.00	0.44	0.00	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	10.11	2.43	0.51	0.26	0.13	0.13	0.77	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	4.56	2.60	2.28	0.00	0.00	0.00	0.98	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	8.27	3.54	0.59	0.00	0.59	0.30	0.59	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	11.82	4.70	1.00	0.43	0.14	0.00	0.28	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	3.09	1.30	0.65	0.00	0.16	0.16	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	5.18	1.52	0.00	0.61	0.00	0.30	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	4.80	0.51	0.25	0.00	0.00	0.25	0.51	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	24.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	8.11	3.34	0.48	0.48	0.00	0.00	0.00	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	7.82	3.24	0.29	0.29	0.29	0.88	0.29	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	10.55	1.29	0.43	0.00	0.22	0.00	0.22	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	6.09	1.89	0.31	0.10	0.31	0.10	0.21	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	4.18	0.93	0.77	0.15	0.15	0.00	0.00	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	11.86	1.08	0.00	1.08	2.16	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	4.48	0.90	0.00	0.30	0.30	0.30	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	7.51	2.39	1.71	0.68	0.00	0.68	0.00	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	9.03	1.57	0.55	0.16	0.31	0.24	0.16	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	7.04	1.21	0.30	0.10	0.30	0.00	0.10	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	8.87	3.19	0.46	0.68	0.00	0.00	0.23	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	6.04	1.81	1.21	0.00	0.60	0.60	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	3.44	0.79	0.00	0.26	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	6.79	1.86	0.00	0.27	0.40	0.27	0.40	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	10.64	4.26	0.88	0.13	0.50	0.38	0.00	0.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	4.31	1.52	0.51	0.25	0.00	0.00	0.51	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	5.88	1.51	1.06	0.30	0.45	0.30	0.15	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	8.25	0.00	1.50	0.00	0.75	0.00	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	27.14	6.46	3.88	0.00	0.00	0.00	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	6.98	0.47	0.93	0.00	0.00	0.47	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	8.58	2.52	1.51	0.00	0.50	0.00	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	10.66	2.19	0.94	0.00	0.31	0.00	0.63	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	4.42	1.18	0.00	0.29	0.29	0.59	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	4.42	1.25	0.25	0.00	0.08	0.17	0.42	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	4.20	0.47	0.00	0.47	0.00	0.00	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	11.08	2.01	0.29	0.00	0.00	0.14	0.14	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	16.06	4.33	0.76	0.25	0.25	0.51	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	6.77	2.26	1.13	0.19	0.56	0.00	0.00	0.75
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	8.38	2.10	0.56	0.00	0.28	0.28	0.42	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	11.14	3.27	0.84	0.17	0.34	0.42	0.25	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	1.90	0.48	0.00	0.00	0.00	0.00	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	9.30	4.40	1.22	0.24	0.73	0.98	0.49	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	9.50	2.43	1.99	0.44	0.44	0.22	1.10	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	2.93	0.59	0.00	0.00	0.29	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	9.91	2.72	0.39	0.39	0.19	0.39	0.19	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	4.76	0.79	0.26	0.00	0.00	0.00	0.00	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	10.41	1.12	0.00	0.37	0.37	0.37	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	7.91	1.08	0.72	0.00	0.00	0.36	0.00	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	1.99	0.57	0.00	0.00	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	9.06	2.36	0.00	0.00	0.39	0.00	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	7.36	0.76	0.51	0.25	0.00	0.76	0.00	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	13.58	0.00	0.40	0.40	0.40	0.00	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	5.85	0.00	0.42	0.00	0.42	0.00	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	5.50	0.92	1.38	0.00	0.46	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	15.49	3.20	1.35	0.34	0.67	0.50	0.34	0.34
Synoviocyte, donor2	11368-117I9	11.06	3.35	0.84	0.34	0.00	0.00	0.34	0.00
Synoviocyte, donor3	11440-118H9	7.60	2.68	0.00	0.45	0.22	0.22	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	7.15	1.79	0.00	0.00	0.71	0.71	0.71	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	9.91	3.96	1.98	0.00	0.00	0.00	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	11.11	4.40	1.16	0.00	0.46	0.23	0.46	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	9.25	0.86	0.07	0.07	0.29	0.14	0.07	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	6.96	1.16	0.39	0.39	0.00	0.00	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	8.59	1.72	0.00	0.00	0.00	1.15	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	21.90	8.49	0.98	1.11	0.37	0.37	0.62	0.25
Urethra, donor2	10319-105A4	53.95	7.19	0.00	3.60	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	11.16	1.06	0.53	0.00	0.80	0.53	0.00	0.00
Urothelial Cells, donor2	11600-120H7	13.22	0.00	0.40	0.00	0.40	0.00	0.40	0.00
Urothelial Cells, donor3	11681-122H7	10.09	1.60	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	17.83	2.23	0.45	0.89	1.56	0.22	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	41.82	22.24	2.67	1.78	1.78	0.89	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	27.16	31.45	2.86	4.29	2.86	0.00	2.86	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	32.17	30.80	3.42	5.48	0.00	2.05	2.05	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	32.71	23.41	2.07	2.07	1.38	1.03	0.69	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	31.96	16.27	0.58	3.49	1.16	2.32	0.00	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	29.15	29.15	0.00	1.04	1.04	3.12	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	45.89	24.78	0.92	2.75	2.75	0.00	1.84	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	24.65	27.39	1.83	0.91	0.91	0.91	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	3.33	2.22	0.12	0.12	0.12	0.37	0.00	0.00
Wilms' tumor cell line:HFWT	10597-108E3	5.28	2.64	0.00	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	16.20	1.68	0.28	0.56	0.56	0.56	0.84	0.00
achilles tendon, donor2	10292-104G4	10.33	16.53	2.07	0.00	0.00	0.00	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	12.24	12.75	1.02	0.51	0.76	0.51	0.00	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	4.41	6.97	0.46	1.39	1.16	0.23	0.23	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	13.41	5.10	0.36	0.47	1.66	1.07	0.83	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	56.33	8.98	0.00	0.27	13.61	3.81	0.27	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	93.04	4.50	0.00	0.28	38.23	10.12	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	73.60	11.42	1.69	0.21	20.94	6.98	0.85	0.85
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	43.01	17.15	2.72	0.82	13.88	2.72	0.82	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	97.38	8.81	0.44	0.44	11.90	1.76	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	32.67	17.97	2.86	0.41	16.74	4.49	0.82	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	28.35	14.76	0.78	1.16	8.54	3.49	1.55	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	31.83	9.38	0.92	0.18	10.86	2.39	0.55	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	156.02	105.31	3.90	0.00	54.61	7.80	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	130.13	17.43	2.09	0.70	18.13	4.88	0.70	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	46.60	23.30	1.81	1.04	14.50	4.40	1.04	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	35.95	29.81	2.05	1.75	5.55	1.75	1.75	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	30.67	11.62	0.93	3.25	0.93	0.00	0.46	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	77.32	11.52	0.82	0.82	16.04	3.29	0.41	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	16.88	3.99	0.00	0.00	0.92	0.31	0.31	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	18.78	11.52	1.28	1.28	2.99	0.85	1.71	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	18.20	10.31	2.43	0.30	2.12	0.91	0.30	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	22.39	12.04	1.93	1.20	2.17	0.48	1.20	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	25.17	9.80	0.89	0.22	5.12	1.56	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	14.68	4.00	0.67	0.00	3.34	0.00	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	18.58	14.87	1.86	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	91.15	17.33	3.77	0.75	7.53	3.39	0.75	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	58.01	17.88	1.31	0.00	16.57	5.23	0.87	1.31
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	164.95	61.86	7.50	3.75	9.37	3.75	1.87	1.87
adenocarcinoma cell line:IM95m	10796-110I4	28.50	3.30	0.71	2.12	0.47	1.18	0.00	0.24
adipose tissue, adult, pool1	10010-101C1	27.15	13.96	2.02	1.24	0.47	0.31	0.93	0.62
adipose, donor1	10184-103D4	11.73	2.93	0.00	0.00	2.93	6.45	0.00	0.00
adipose, donor2	10185-103D5	5.68	1.62	0.00	0.00	0.41	0.00	0.41	0.00
adipose, donor3	10186-103D6	14.43	2.45	0.54	0.00	0.82	0.54	0.54	0.00
adipose, donor4	10187-103D7	17.34	2.60	0.87	0.00	0.87	2.60	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	5.21	3.00	0.00	0.16	0.32	0.47	0.32	0.00
adrenal gland, adult, pool1	10081-102A9	14.55	7.28	3.64	0.00	3.64	0.00	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	4.67	7.60	0.00	0.27	0.13	0.00	0.13	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	12.15	2.50	1.07	0.36	0.36	0.71	0.71	0.36
amniotic membrane cells, donor1	12235-129G3	12.98	1.16	0.00	0.46	0.00	0.00	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	8.45	0.34	0.34	0.34	0.00	0.00	0.00	0.34
amniotic membrane cells, donor3	12237-129G5	10.02	0.59	0.00	0.29	0.29	0.88	0.00	0.00
amygdala - adult, donor10196	10167-103B5	10.67	5.93	2.37	2.37	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	16.83	10.54	1.01	1.62	0.41	0.00	0.20	0.20
amygdala, newborn, donor10223	10360-105E9	16.46	4.20	0.32	0.00	0.65	0.00	0.00	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	65.57	11.84	3.95	0.76	2.29	1.40	1.53	0.51
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	20.08	31.33	1.32	2.21	0.22	0.00	0.22	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	15.37	1.00	0.33	0.67	1.00	1.34	0.67	0.33
aorta, adult, pool1	10052-101G7	45.31	14.71	4.31	0.78	0.78	0.98	1.18	0.78
appendix, adult	10189-103D9	54.72	38.42	2.33	3.10	2.72	2.33	1.55	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	4.47	2.06	0.00	0.00	0.69	0.69	0.00	0.00
artery, adult	10190-103E1	6.79	2.72	2.72	0.00	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	49.98	21.73	7.53	1.01	3.77	2.90	4.49	1.16
b cell line:RPMI1788	10427-106D4	17.25	39.41	0.45	2.83	0.45	0.45	0.45	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	10.27	3.61	0.83	0.55	0.55	0.00	0.28	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	57.65	7.74	1.39	0.79	0.60	1.59	0.79	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	30.30	6.86	0.33	0.67	0.17	1.00	0.50	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	40.27	21.25	1.12	4.47	1.68	0.56	0.00	0.00
bladder, adult, pool1	10011-101C2	54.43	9.13	2.93	1.74	0.87	0.65	0.98	0.87
blood, adult, pool1	10053-101G8	6.64	28.79	0.00	4.43	0.00	2.21	4.43	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	14.56	3.43	0.00	0.86	0.00	0.00	0.00	0.86
bone marrow, adult	10192-103E3	18.90	10.12	1.35	0.67	0.00	1.35	0.67	0.67
brain, adult, donor1	10084-102B3	8.20	2.05	0.00	1.03	1.03	0.00	0.00	1.03
brain, adult, pool1	10012-101C3	12.81	5.79	0.89	0.33	0.56	0.56	1.11	0.11
brain, fetal, pool1	10085-102B4	13.36	5.34	0.00	0.00	0.00	0.00	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	5.62	0.66	0.33	0.33	0.00	0.33	0.00	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	37.95	3.99	0.62	0.75	0.75	2.37	0.25	0.00
breast, adult, donor1	10080-102A8	23.36	9.47	0.63	1.26	1.89	0.63	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	14.36	3.05	0.51	0.13	0.13	0.76	0.38	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	15.46	5.57	1.86	0.62	1.55	0.31	0.62	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	26.48	4.60	0.00	0.46	2.30	4.60	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	5.81	1.45	0.48	0.00	0.00	0.24	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	6.58	1.41	0.00	0.00	0.94	0.94	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	34.78	12.14	1.31	1.64	0.88	2.08	0.44	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	5.39	0.32	0.00	0.00	0.00	0.32	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	5.86	1.60	0.00	0.00	0.27	0.00	0.53	0.00
caudate nucleus - adult, donor10196	10177-103C6	21.88	8.06	2.30	0.00	2.30	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	8.53	7.36	1.17	0.50	0.17	0.67	0.33	0.33
caudate nucleus, adult, donor10258	10379-105H1	5.35	5.35	0.00	0.76	0.76	0.76	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	20.88	6.96	1.10	0.73	0.37	0.37	0.00	0.37
cerebellum - adult, donor10196	10173-103C2	5.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	10.89	4.06	0.85	0.43	0.00	0.21	0.00	0.00
cerebellum, adult, pool1	10083-102B2	3.45	2.76	0.00	0.00	0.00	0.34	0.34	0.00
cerebellum, newborn, donor10223	10357-105E6	26.57	4.15	2.49	0.00	1.66	0.83	0.00	0.83
cerebral meninges, adult	10188-103D8	7.31	2.77	0.25	0.50	0.50	0.00	0.76	0.50
cerebrospinal fluid, donor2	10294-104G6	8.77	6.58	0.73	0.73	0.73	0.73	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	8.63	0.58	0.14	0.00	0.00	1.01	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	18.56	1.16	0.50	0.50	0.00	0.50	0.00	0.33
cervix, adult, pool1	10013-101C4	37.80	9.55	2.10	0.94	0.42	1.15	0.84	0.73
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	33.44	7.38	1.25	1.11	0.56	0.56	0.42	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	7.84	1.31	0.00	1.31	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	15.53	11.81	1.74	0.75	2.61	2.24	0.87	0.25
choriocarcinoma cell line:SCH	10785-110H2	8.26	3.20	0.37	0.25	1.11	1.11	0.00	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	9.96	2.37	0.24	0.95	0.24	1.19	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	9.40	1.71	0.00	0.28	0.00	0.28	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	11.04	3.08	1.19	0.40	0.20	0.40	0.20	0.20
chorionic membrane cells, donor3	12240-129G8	23.63	3.85	0.55	0.00	0.00	2.20	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	5.05	3.03	0.00	1.01	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	55.32	17.87	1.92	0.58	15.94	4.42	1.92	1.15
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	34.00	19.64	5.28	1.69	5.91	2.32	2.53	0.84
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	5.39	1.28	0.00	0.00	0.00	0.26	0.26	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	4.35	2.18	0.00	0.24	0.73	0.24	0.24	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	5.09	2.44	0.41	0.20	0.00	0.81	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	4.12	2.94	0.00	0.00	0.29	0.00	0.29	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	101.90	33.10	7.56	2.35	22.15	5.21	3.13	2.09
clear cell carcinoma cell line:JHOC-5	10638-108I8	10.74	0.69	0.00	0.00	0.46	0.91	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	24.46	5.73	1.04	0.35	1.04	1.74	0.87	0.35
colon carcinoma cell line:CACO-2	10513-107D9	4.94	3.48	0.18	0.00	0.55	0.18	0.18	0.00
colon carcinoma cell line:COLO-320	10420-106C6	17.10	1.52	0.00	0.00	0.38	1.14	0.00	0.00
colon, adult, donor1	10082-102B1	39.27	14.28	1.19	2.38	0.00	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	44.06	10.81	0.94	2.00	0.47	1.41	0.24	0.00
colon, fetal, donor1	10070-101I7	37.70	11.12	1.24	2.47	0.00	1.24	0.62	0.62
common myeloid progenitor CMP, donor1	12130-128D6	403.35	352.93	18.33	9.17	146.67	55.00	18.33	4.58
common myeloid progenitor CMP, donor2	12134-128E1	125.18	75.11	25.04	0.00	0.00	25.04	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	9.35	27.62	12.75	2.12	0.42	0.42	1.70	2.55
cord blood derived cell line:COBL-a 24h infection	10453-106G3	2.72	18.56	11.92	0.15	0.60	0.30	4.08	2.26
cord blood derived cell line:COBL-a untreated	10449-106F8	4.51	22.70	15.93	0.14	0.42	0.14	5.64	1.69
corpus callosum, adult, pool1	10042-101F6	19.68	12.60	1.77	1.22	0.22	0.88	0.33	0.22
cruciate ligament, donor2	10295-104G7	32.42	14.59	1.62	1.62	0.00	0.00	0.00	2.43
diaphragm, fetal, donor1	10069-101I6	13.64	0.80	0.80	0.00	0.00	1.61	0.00	0.00
diencephalon, adult	10193-103E4	6.24	1.68	0.48	0.48	0.24	0.00	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	52.81	8.50	0.00	1.38	3.90	2.30	0.23	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	29.49	6.15	0.51	0.51	0.26	1.80	0.51	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	14.44	4.09	1.93	0.48	0.72	0.72	0.72	0.00
ductus deferens, adult	10196-103E7	33.39	6.48	0.50	1.00	0.00	1.00	1.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	31.69	2.88	1.44	0.00	0.00	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	39.73	14.71	4.41	1.47	1.47	1.47	1.47	2.21
dura mater, adult, donor1	10041-101F5	49.30	67.64	10.24	4.05	0.41	0.41	3.39	2.56
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	6.44	0.89	0.00	0.22	0.00	0.00	0.00	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	4.73	1.00	0.14	0.00	0.14	0.57	0.14	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	6.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	9.08	0.91	0.00	0.30	0.61	0.61	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	8.34	2.78	0.00	0.31	0.62	0.00	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	11.82	3.94	1.31	0.00	1.31	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	18.44	15.42	0.67	0.67	0.34	1.01	0.67	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	9.97	2.36	0.00	0.72	0.54	1.81	0.00	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	7.24	2.09	0.80	0.00	0.48	1.13	0.00	0.00
epidermoid carcinoma cell line:A431	10426-106D3	31.24	3.33	0.78	0.67	0.44	0.78	0.44	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	30.91	5.28	0.44	0.77	0.99	1.21	0.44	0.00
epididymis, adult	10197-103E8	36.84	12.56	3.77	1.67	1.05	0.84	1.88	2.30
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	5.85	0.89	0.00	0.18	0.00	0.89	0.00	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	2.36	1.57	0.00	0.00	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	11.40	1.44	0.13	0.26	0.13	0.92	0.13	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	17.62	2.46	0.30	0.39	0.30	0.59	0.10	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	11.43	0.90	0.11	0.45	0.11	0.90	0.11	0.22
esophagus, adult, pool1	10015-101C6	32.38	6.16	0.96	0.85	0.32	0.96	0.42	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	14.90	4.01	0.25	0.25	0.13	0.63	0.13	0.13
eye - muscle inferior rectus, donor1	10272-104E2	53.12	12.07	0.00	2.41	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	6.31	8.42	0.00	0.00	0.00	0.00	0.00	2.10
eye - muscle medial, donor2	10299-104H2	14.88	0.00	1.49	2.98	1.49	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	13.76	8.03	0.00	1.15	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	24.78	11.66	0.00	1.46	0.00	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	13.22	4.83	1.27	0.76	0.25	0.25	0.25	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	26.67	5.51	1.15	0.77	1.41	0.51	1.28	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	22.32	2.14	0.71	1.90	0.71	0.47	0.71	0.00
frontal lobe, adult, pool1	10040-101F4	14.17	3.38	1.41	0.94	0.56	0.47	0.38	0.38
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	12.91	3.90	0.00	0.30	0.30	0.90	0.30	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	41.42	8.60	0.73	1.01	1.28	1.19	0.37	0.27
gall bladder, adult	10198-103E9	39.11	14.97	2.90	0.97	0.72	0.24	1.21	1.45
gamma delta positive T cells, donor1	11937-126A2	20.94	6.44	0.54	1.07	0.54	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	20.17	9.71	1.49	1.12	1.49	0.37	1.12	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	9.93	1.27	0.00	0.21	0.42	0.21	0.00	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	28.43	6.77	0.58	0.97	0.77	1.16	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	12.30	5.90	0.49	0.33	1.31	1.64	0.33	0.16
gastric cancer cell line:GSS	10560-108A2	2.75	0.92	0.00	0.00	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	5.71	5.94	0.00	0.00	0.69	0.91	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	8.15	0.34	0.00	0.11	0.11	0.34	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	13.58	2.38	0.70	0.42	0.28	0.42	0.56	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	31.18	3.99	1.00	2.00	0.00	1.00	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	5.49	2.01	0.95	0.11	0.11	0.42	0.21	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	4.07	0.98	0.70	0.00	0.42	0.14	0.42	0.14
glioblastoma cell line:T98G	10485-107A8	13.58	6.95	1.43	0.33	0.22	0.33	0.77	0.44
glioma cell line:GI-1	10413-106B8	6.15	2.64	0.88	0.29	0.29	0.29	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	13.12	5.10	1.46	1.46	0.00	0.73	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	32.95	16.11	1.71	1.46	0.00	1.46	1.22	0.49
globus pallidus, adult, donor10258	10367-105F7	8.22	5.48	4.11	1.37	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	20.25	5.33	0.53	0.00	1.07	0.00	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	264.29	526.14	19.58	29.37	66.07	17.13	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	21.86	0.00	10.93	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	36.59	0.00	0.00	0.00	5.23	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	11.84	2.88	0.96	0.32	0.00	0.64	0.96	0.00
hIPS +CCl2, biol_rep1	14383-156B9	4.59	0.46	0.46	0.00	0.00	1.38	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	4.12	1.83	0.46	0.00	0.91	1.83	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	3.86	1.93	0.00	0.64	0.64	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	0.00	0.00	0.00	1.44	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	2.74	0.69	0.69	0.00	1.37	0.69	0.00	0.00
hIPS, biol_rep3	14382-156B8	9.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	7.47	9.77	0.86	1.72	0.00	0.00	1.15	0.00
heart - mitral valve, adult	10205-103F7	29.90	11.66	1.49	1.20	1.49	0.30	0.30	1.49
heart - pulmonic valve, adult	10206-103F8	29.81	14.38	1.83	1.31	0.52	0.78	0.78	1.05
heart - tricuspid valve, adult	10207-103F9	60.78	29.14	0.83	4.16	0.00	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	11.84	2.86	0.41	0.61	0.41	0.61	0.41	0.20
heart, adult, diseased, donor1	10051-101G6	17.88	3.41	1.28	1.28	0.43	0.43	0.00	0.00
heart, adult, pool1	10016-101C7	17.71	5.06	0.46	1.15	0.00	0.46	0.23	0.00
heart, fetal, pool1	10046-101G1	37.79	9.65	2.05	1.03	0.92	1.13	0.72	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	22.21	4.63	4.01	0.31	0.93	0.00	0.93	1.23
hepatoblastoma cell line:HuH-6	10633-108I3	10.70	3.57	0.00	1.19	0.00	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	4.86	2.54	0.22	0.11	0.33	0.55	0.11	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	4.98	2.06	0.00	0.36	0.36	0.49	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	5.96	3.13	0.40	0.20	0.20	1.01	0.20	0.10
hepatoma cell line:Li-7	10484-107A7	13.12	4.34	0.33	0.44	0.22	1.33	0.22	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	14.37	15.78	0.80	1.71	0.60	0.40	0.40	0.10
hippocampus - adult, donor10196	10169-103B7	11.36	2.84	0.00	0.95	0.95	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	22.04	10.61	1.22	1.63	0.00	1.02	0.61	0.00
hippocampus, adult, donor10258	10374-105G5	3.49	1.49	0.00	0.00	0.00	1.00	0.00	0.50
hippocampus, newborn, donor10223	10363-105F3	8.46	2.11	1.06	0.00	0.70	0.70	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	12.82	6.10	1.83	0.00	1.22	1.83	0.00	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	6.28	3.93	0.39	0.20	1.37	0.98	0.20	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	8.38	3.55	0.51	0.25	2.03	0.76	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	7.33	3.95	0.00	0.00	1.13	5.07	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	9.81	5.42	0.26	0.00	1.81	2.58	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	6.83	5.31	0.38	0.00	2.66	3.42	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	9.34	3.80	0.29	0.29	0.88	2.34	0.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	9.05	3.45	0.43	0.22	1.08	1.29	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	12.51	5.00	0.42	0.00	0.42	2.09	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	10.18	4.74	0.95	0.00	0.47	1.89	0.24	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	11.25	3.54	0.64	0.16	0.80	1.45	0.16	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	13.47	2.69	0.00	0.67	0.00	1.35	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	3.76	2.66	0.16	0.00	1.41	0.78	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	6.88	0.98	0.00	0.49	0.49	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	2.62	2.62	0.00	0.00	0.00	0.87	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	8.59	5.92	0.19	0.00	2.10	1.72	0.38	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	8.72	3.49	0.00	0.00	2.18	3.49	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	11.49	4.00	0.00	0.00	2.00	4.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	6.59	0.94	0.75	0.19	0.75	1.13	0.19	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	8.64	0.91	0.45	0.00	0.91	1.82	0.45	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	7.83	0.63	0.31	0.00	1.25	1.25	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	8.65	2.61	1.47	0.16	0.82	0.98	0.49	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	10.74	1.74	0.29	0.00	0.00	1.16	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	17.04	2.99	0.60	0.00	0.00	0.30	0.60	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	4.80	3.14	0.55	0.00	1.66	1.48	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	3.99	3.42	0.00	0.00	1.14	0.57	0.57	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	10.21	1.63	0.00	0.00	0.82	0.00	0.41	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	6.34	2.46	0.35	0.00	2.11	1.76	1.06	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	7.92	2.22	0.63	0.00	2.22	0.95	0.00	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	9.68	3.03	0.00	0.00	0.30	0.30	0.00	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	9.31	3.10	0.00	0.00	0.52	0.00	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	6.64	3.32	0.00	0.00	0.66	2.66	1.33	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	5.90	2.57	0.26	0.00	0.51	0.77	0.26	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	9.97	3.83	0.51	1.02	0.77	0.26	0.26	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	6.82	3.79	0.76	0.00	0.00	0.76	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	12.77	1.34	0.67	0.00	0.34	1.01	0.34	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	5.55	4.11	0.00	0.00	0.72	1.69	0.00	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	4.46	0.89	0.00	0.00	0.45	0.45	0.00	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	11.71	3.41	0.00	0.00	0.49	0.98	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	8.25	2.14	0.31	0.00	1.83	0.92	0.00	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	22.77	6.51	0.00	0.00	3.25	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	14.23	1.99	0.00	0.00	3.31	0.66	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	7.66	6.02	0.55	0.00	0.55	2.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	9.05	1.81	0.00	0.00	0.72	1.45	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	8.19	3.20	0.00	0.00	1.07	3.56	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	5.97	2.39	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	12.73	3.79	0.41	0.00	1.35	1.90	0.27	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	9.16	1.35	0.27	0.00	0.81	0.81	0.27	0.00
immature langerhans cells, donor1	11904-125F5	101.22	30.99	4.60	6.30	1.94	4.12	2.66	1.45
immature langerhans cells, donor2	11905-125F6	64.95	12.67	0.79	3.17	0.79	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	14.48	5.68	1.23	0.38	0.76	0.76	0.66	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	2.93	0.98	0.65	0.00	0.00	0.00	0.00	0.00
kidney, adult, pool1	10017-101C8	22.43	7.61	1.00	0.40	0.20	0.30	0.50	0.10
kidney, fetal, pool1	10045-101F9	33.39	10.68	2.19	0.85	0.99	1.56	0.78	0.57
large cell lung carcinoma cell line:IA-LM	10509-107D5	46.30	6.39	0.99	0.99	1.85	2.56	1.14	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	2.76	0.28	0.00	0.28	0.14	0.00	0.00	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	24.41	4.04	1.65	0.37	0.55	0.55	0.37	0.18
left atrium, adult, donor1	10079-102A7	16.89	2.18	1.63	0.54	0.00	0.54	0.00	0.54
left ventricle, adult, donor1	10078-102A6	13.15	1.01	0.00	0.51	0.00	0.00	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	4.10	1.64	0.27	0.00	0.27	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	2.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	2.17	0.54	0.00	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	2.43	0.24	0.24	0.00	0.00	0.00	0.00	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	17.77	3.14	1.05	1.05	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	56.55	27.86	2.72	1.65	3.78	2.95	1.30	0.35
liposarcoma cell line:KMLS-1	10782-110G8	15.93	3.59	1.56	0.94	0.16	0.16	0.78	0.31
liposarcoma cell line:SW 872	10726-110A6	15.23	8.41	0.97	0.49	0.37	0.85	0.37	0.00
liver, adult, pool1	10018-101C9	18.15	9.72	0.65	1.13	0.16	0.32	0.49	0.32
liver, fetal, pool1	10086-102B5	3.76	4.70	0.00	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	22.17	14.44	1.75	1.02	0.00	0.29	0.29	0.73
locus coeruleus, adult, donor10252	10165-103B3	19.56	16.06	2.21	1.66	0.18	0.18	0.55	0.18
locus coeruleus, adult, donor10258	10375-105G6	5.92	1.69	0.00	0.28	0.28	0.00	0.00	0.00
locus coeruleus, newborn, donor10223	10362-105F2	23.55	2.94	2.52	0.00	0.42	0.42	0.00	0.42
lung adenocarcinoma cell line:A549	10499-107C4	7.06	1.25	0.14	0.55	0.14	0.28	0.14	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	61.36	13.10	1.38	1.38	0.00	2.76	2.07	1.38
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	60.77	30.45	1.32	2.77	1.05	2.24	0.79	0.79
lung, adult, pool1	10019-101D1	27.76	14.88	2.01	1.42	0.47	0.24	0.12	0.47
lung, fetal, donor1	10068-101I5	57.08	18.55	5.14	1.14	2.00	2.57	2.00	0.57
lung, right lower lobe, adult, donor1	10075-102A3	24.74	14.20	0.92	0.00	0.46	0.92	0.00	0.92
lymph node, adult, donor1	10077-102A5	26.98	11.36	0.95	0.95	0.47	1.42	0.95	0.00
lymphangiectasia cell line:DS-1	10727-110A7	7.01	55.89	0.88	1.10	0.00	0.00	1.32	1.10
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	6.94	11.02	0.60	0.30	0.91	0.30	0.30	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	92.59	2.55	0.85	2.55	0.00	1.70	0.85	0.85
mature adipocyte, donor1	12231-129F8	20.87	3.55	0.89	0.44	0.00	0.44	0.00	0.44
mature adipocyte, donor2	12232-129F9	16.19	5.40	1.04	1.04	0.21	0.21	0.42	0.21
mature adipocyte, donor3	12233-129G1	12.80	2.84	1.19	0.47	0.00	0.47	0.00	0.24
mature adipocyte, donor4	12234-129G2	10.00	1.84	0.26	0.26	0.00	0.00	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	22.63	10.25	1.19	0.48	3.10	4.05	1.19	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	13.54	1.13	2.26	0.00	0.00	2.26	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	28.87	11.77	2.57	0.55	1.66	0.74	0.92	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	7.31	2.22	0.95	0.00	0.00	0.00	0.00	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	20.90	0.43	2.56	0.85	1.28	0.43	1.28	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	20.08	7.26	0.51	0.17	0.00	0.84	0.17	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	24.83	11.04	1.49	0.64	0.00	0.64	0.42	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	3.85	0.00	0.00	0.00	0.00	0.00	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	43.06	0.00	14.35	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	16.15	2.15	1.08	0.36	1.79	1.08	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	21.42	3.24	1.95	1.95	0.00	0.00	0.65	1.30
medulla oblongata, adult, donor10252	10155-103A2	26.16	14.55	1.55	0.93	0.46	0.15	0.46	0.62
medulla oblongata, adult, pool1	10038-101F2	19.02	15.92	2.53	0.57	0.33	0.73	0.49	0.41
medulla oblongata, newborn, donor10223	10361-105F1	15.62	6.60	1.04	0.35	1.39	0.35	0.00	1.04
medulloblastoma cell line:D283 Med	10838-111E1	7.31	1.55	0.22	0.00	0.44	1.99	0.22	0.22
medulloblastoma cell line:ONS-76	10759-110E3	17.73	5.26	0.73	0.49	1.10	0.49	0.73	0.12
melanoma cell line:COLO 679	10514-107E1	11.93	1.44	0.43	0.14	0.43	0.43	0.72	0.29
melanoma cell line:G-361	10465-106H6	10.59	1.90	1.90	0.00	0.81	0.81	0.81	0.27
meningioma cell line:HKBMM	10691-109F7	50.29	13.93	2.53	2.17	1.45	0.72	0.54	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	24.67	7.93	1.76	0.00	3.52	1.76	0.88	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	15.55	5.44	0.00	0.00	1.30	2.33	0.52	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	8.75	2.15	0.31	0.15	0.00	0.00	0.61	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	11.45	2.00	0.36	0.00	0.36	0.18	0.36	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	3.31	1.24	0.00	0.00	0.41	0.00	0.83	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	7.59	1.83	0.70	0.70	0.28	0.14	0.70	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	9.05	3.27	0.19	0.19	0.00	0.19	0.19	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	9.72	5.55	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	6.18	1.20	0.00	0.34	0.00	0.34	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	7.82	1.04	0.23	0.12	0.35	0.23	0.35	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	5.70	2.12	0.53	0.66	0.40	0.27	0.40	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	6.48	2.70	0.95	0.54	0.41	0.54	0.27	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	8.54	2.70	0.43	0.00	0.43	0.43	1.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	7.58	2.63	0.33	0.66	0.00	0.00	0.33	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	12.87	2.08	1.66	0.69	0.55	0.42	0.97	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	8.03	0.70	0.00	0.35	0.00	0.70	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	6.74	2.04	0.82	0.41	0.00	0.00	0.61	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	11.86	3.59	0.72	1.08	1.08	0.00	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	7.76	2.28	0.41	0.41	0.10	0.00	0.21	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	6.38	2.28	0.23	0.00	0.00	0.46	0.23	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	13.01	2.94	0.84	0.42	0.84	0.00	1.26	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	13.15	2.54	0.60	0.60	0.00	0.15	0.60	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	10.15	3.59	0.44	0.26	0.00	0.09	0.35	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	6.26	2.21	0.37	0.37	0.37	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	16.31	4.86	2.58	0.57	0.29	0.00	1.43	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	4.63	1.26	0.42	0.00	0.00	0.00	0.42	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	7.76	2.74	0.46	0.46	0.00	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	10.23	1.53	0.77	1.02	0.00	0.00	0.51	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	11.26	1.83	0.79	0.26	0.00	0.52	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	13.25	1.54	0.62	0.62	0.31	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	9.65	2.12	0.24	0.00	0.24	0.24	0.71	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	11.17	2.03	1.02	0.00	0.00	0.34	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	9.82	1.18	0.79	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	6.95	3.24	0.46	0.00	0.00	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00	48.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	9.52	1.73	0.87	0.00	0.00	0.29	0.58	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	10.26	1.12	0.45	0.22	0.00	0.22	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	9.85	1.68	0.00	0.00	0.24	0.24	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	11.73	3.67	0.00	2.20	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	10.41	1.01	0.67	0.00	0.34	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	9.83	1.23	0.82	0.41	0.00	0.00	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	5.58	0.43	0.43	0.00	0.00	0.00	0.86	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	5.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	36.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	9.09	1.30	0.65	0.32	0.00	0.00	0.32	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	11.64	1.45	1.45	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	5.33	1.60	0.00	0.00	0.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	6.54	0.82	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	7.39	0.78	0.78	0.00	0.00	0.00	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	6.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	1.99	0.00	0.99	0.99	0.99	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	0.00	0.00	0.00	0.00	0.00	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	8.30	0.00	0.00	0.00	0.00	0.59	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	8.53	3.66	0.00	1.22	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	6.97	3.17	0.63	0.00	0.63	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	11.73	2.07	0.34	0.34	0.00	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	15.04	0.00	2.15	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	19.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	27.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	9.37	1.22	0.81	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	11.92	2.38	0.00	0.00	2.38	1.59	1.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	5.31	0.00	0.00	0.00	0.59	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	7.79	1.25	0.94	0.00	0.62	0.00	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	6.68	0.00	0.00	1.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	4.73	0.00	0.00	0.00	0.00	1.18	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	17.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	10.33	2.07	0.69	0.00	2.75	1.38	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	5.94	0.99	0.49	0.49	0.00	0.49	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	6.73	0.00	0.00	0.00	1.12	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	1.91	0.64	0.00	0.00	0.64	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	3.63	0.40	0.00	0.00	0.00	0.40	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	4.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	3.80	1.27	0.00	0.00	0.00	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	6.68	1.82	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	4.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	5.77	1.65	0.00	0.00	0.00	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	4.96	0.79	0.20	0.20	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	4.22	0.65	0.00	0.65	0.00	0.32	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	4.07	1.02	0.00	0.00	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	17.02	10.83	2.32	2.32	0.00	0.77	0.77	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	10.39	1.65	0.00	0.47	0.00	0.71	0.24	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	9.27	4.40	1.39	0.23	0.70	0.70	0.93	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	34.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	11.61	2.16	1.34	0.21	0.21	0.21	0.31	0.31
mesothelioma cell line:Mero-25	10850-111F4	28.37	7.04	0.68	0.45	0.68	0.23	0.00	0.23
mesothelioma cell line:Mero-41	10851-111F5	16.87	7.33	1.22	0.00	0.49	0.24	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	15.94	6.64	0.44	0.89	0.89	0.22	0.66	0.22
mesothelioma cell line:Mero-82	10853-111F7	16.56	3.42	0.00	0.53	0.00	0.53	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	11.40	1.53	0.34	0.34	0.17	1.36	0.34	0.00
mesothelioma cell line:Mero-84	10855-111F9	11.88	2.53	0.51	0.76	1.01	0.00	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	25.88	6.42	2.07	0.21	1.04	0.62	0.41	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	15.41	3.64	0.66	0.33	1.33	0.50	0.33	0.17
mesothelioma cell line:NCI-H226	10846-111E9	10.86	3.80	0.00	0.18	0.00	0.00	0.18	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	8.54	4.10	0.51	0.34	0.00	0.00	0.00	0.00
mesothelioma cell line:NCI-H28	10845-111E8	9.16	2.80	0.25	0.25	0.51	0.00	0.00	0.00
mesothelioma cell line:No36	10857-111G2	5.22	0.65	0.00	0.33	0.00	0.33	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	7.04	1.63	0.54	0.54	0.54	0.54	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	15.35	99.61	4.99	2.30	0.19	0.00	2.69	1.73
migratory langerhans cells, donor2	11902-125F3	10.14	85.85	2.69	1.83	0.00	0.12	0.49	0.61
migratory langerhans cells, donor3	11903-125F4	12.03	98.00	3.05	2.51	0.18	0.18	1.26	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	18.94	3.92	0.33	0.00	0.98	0.00	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	15.47	2.54	0.42	0.85	0.21	0.85	0.42	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	14.05	2.76	0.00	0.69	0.23	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	6.47	7.99	0.95	0.95	0.38	0.57	0.76	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	44.35	13.31	2.59	0.74	15.15	2.40	0.74	0.37
myeloma cell line:PCM6	10474-106I6	12.65	10.08	0.40	1.98	0.00	0.20	0.00	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	4.57	0.00	0.00	1.01	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	7.45	1.77	0.20	0.59	0.39	0.39	0.20	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	9.69	0.89	0.00	0.11	0.00	0.45	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	13.60	0.37	0.15	0.15	0.07	0.44	0.00	0.00
nasal epithelial cells, donor2	12227-129F4	21.53	2.76	0.00	0.55	0.55	0.55	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	6.21	2.30	0.23	0.00	0.00	2.30	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	29.00	11.04	3.18	0.37	2.43	1.87	1.68	1.12
neuroblastoma cell line:NBsusSR	10607-108F4	7.80	4.43	0.21	0.21	0.84	0.84	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	10.44	5.96	1.12	0.19	0.75	0.93	0.37	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	12.57	0.95	0.24	0.00	0.47	0.95	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	29.46	4.12	1.58	0.79	0.95	1.11	0.79	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	7.04	2.21	0.20	0.00	0.40	0.40	0.60	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	5.09	0.64	0.00	0.00	0.00	0.64	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	16.77	3.46	0.80	0.27	0.27	0.00	0.53	0.00
neutrophil PMN, donor1	12133-128D9	29.75	14.87	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	8.46	15.73	1.01	0.85	0.85	1.69	0.00	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	10.41	9.61	0.00	0.00	2.40	0.00	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	5.45	1.60	0.96	0.32	0.64	0.32	0.00	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	4.20	1.84	0.53	0.26	0.00	0.26	0.26	0.00
nucleus accumbens, adult, pool1	10037-101F1	12.28	6.66	0.94	0.66	0.28	0.37	0.47	0.37
occipital cortex - adult, donor10196	10172-103C1	18.54	4.12	0.00	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	35.69	17.18	1.34	1.34	1.07	1.07	0.81	0.27
occipital cortex, newborn, donor10223	10355-105E4	24.02	4.00	1.82	0.00	1.46	0.00	0.73	0.00
occipital lobe, adult, donor1	10076-102A4	11.28	2.36	0.52	0.52	0.26	0.26	0.26	0.26
occipital lobe, fetal, donor1	10073-102A1	17.16	3.43	0.43	0.00	2.15	0.43	0.00	0.00
occipital pole, adult, pool1	10036-101E9	12.46	3.23	0.95	0.32	0.79	0.79	0.95	0.47
olfactory region, adult	10195-103E6	10.32	3.25	0.38	1.34	0.00	0.19	0.38	0.00
optic nerve, donor1	10277-104E7	8.00	2.00	0.00	0.00	0.00	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	23.92	6.38	0.57	0.34	1.82	1.59	0.34	0.46
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	8.66	0.69	0.14	0.00	0.27	0.82	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	16.09	3.22	1.02	0.51	0.17	0.68	0.00	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	21.83	6.12	1.16	1.39	0.35	0.23	0.69	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	18.81	5.59	1.47	0.59	0.29	0.88	0.29	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	48.59	15.88	0.93	1.87	2.80	0.93	2.80	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	5.73	2.54	0.00	0.00	0.21	0.64	0.00	0.00
ovary, adult, pool1	10020-101D2	28.91	8.74	1.40	0.70	0.70	0.26	0.87	0.44
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	12.83	3.48	0.37	0.37	1.10	0.55	0.00	0.00
pancreas, adult, donor1	10049-101G4	26.34	3.76	0.00	0.94	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	19.01	11.46	1.12	1.12	0.56	1.40	0.56	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	8.69	2.38	0.85	0.85	0.00	0.34	0.00	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	63.75	10.93	2.98	0.66	1.66	2.48	1.16	0.83
paracentral gyrus, adult, pool1	10035-101E8	10.34	4.58	0.92	0.27	0.46	0.64	1.37	0.18
parietal cortex, adult, donor10258	10373-105G4	6.61	0.73	1.47	0.00	0.00	1.47	0.00	0.73
parietal lobe - adult, donor10196	10171-103B9	8.46	5.64	0.94	0.94	0.00	0.00	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	26.79	9.41	0.86	0.86	1.71	0.57	0.86	0.29
parietal lobe, adult, pool1	10034-101E7	13.83	4.32	0.88	0.35	0.44	0.62	0.79	0.35
parietal lobe, fetal, donor1	10072-101I9	20.37	2.91	0.00	0.00	4.85	0.00	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	23.55	3.36	1.50	0.00	2.99	1.50	0.37	0.00
parotid gland, adult	10199-103F1	72.77	19.12	0.62	2.47	1.85	1.23	0.62	0.62
penis, adult	10200-103F2	41.89	16.65	1.07	1.07	1.07	1.07	2.69	2.69
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	4.46	0.56	0.00	0.19	0.19	0.37	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	28.85	16.46	1.17	1.31	0.87	0.44	1.17	0.44
pineal gland - adult, donor10196	10179-103C8	19.35	3.23	0.65	1.29	0.00	0.65	0.00	0.65
pineal gland, adult, donor10252	10160-103A7	18.36	7.70	1.18	0.00	0.59	0.59	0.59	0.59
pineal gland, adult, donor10258	10377-105G8	7.52	1.88	0.63	0.63	0.63	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	32.38	4.05	0.00	0.00	3.04	3.04	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	55.77	10.94	1.56	0.52	1.56	1.56	0.52	2.61
pituitary gland, adult, donor10258	10378-105G9	21.28	5.11	0.00	0.00	1.70	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	12.36	4.41	1.29	0.11	0.22	0.11	0.11	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	13.90	25.96	1.59	2.38	0.66	0.26	0.53	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	20.08	6.69	1.87	0.16	0.00	0.62	0.47	0.31
pons, adult, pool1	10033-101E6	11.45	7.14	0.69	0.26	0.17	0.34	0.52	0.09
postcentral gyrus, adult, pool1	10032-101E5	12.99	3.75	1.22	0.70	0.44	0.70	1.22	0.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	119.21	248.88	12.55	12.55	16.73	4.18	8.37	4.18
promyelocytes/myelocytes PMC, donor2	12136-128E3	22.03	33.05	0.00	0.00	5.51	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	23.47	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	8.89	0.73	0.15	0.15	0.29	0.58	0.15	0.15
prostate cancer cell line:PC-3	10439-106E7	13.25	1.82	0.18	0.18	0.91	0.91	0.54	0.00
prostate, adult, pool1	10022-101D4	45.26	11.61	2.00	0.73	1.00	1.09	0.63	0.82
putamen, adult, donor10196	10176-103C5	10.86	13.46	0.71	0.71	0.24	0.71	0.24	0.24
putamen, adult, donor10252	10152-102I8	5.88	7.84	0.00	1.96	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	2.19	1.09	0.00	0.00	1.09	0.00	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	6.28	2.90	0.72	0.00	0.00	0.00	0.24	0.00
putamen, newborn, donor10223	10365-105F5	26.24	5.25	1.50	0.75	0.00	0.00	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	9.60	1.45	0.00	1.16	0.00	0.58	0.29	0.00
rectum, fetal, donor1	10067-101I4	44.51	16.69	2.78	0.00	2.78	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	22.90	5.51	0.85	0.21	1.06	0.85	0.21	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	29.41	5.80	1.24	0.83	3.73	1.66	0.00	0.00
retina, adult, pool1	10030-101E3	24.45	11.83	3.48	0.89	0.70	0.50	1.19	0.30
retinoblastoma cell line:Y79	10475-106I7	8.05	3.90	0.26	0.00	1.56	1.04	0.52	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	12.66	5.16	0.74	0.12	0.49	0.74	0.61	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	11.53	11.25	0.00	0.00	1.69	1.97	0.84	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	17.43	4.55	0.00	0.76	0.00	0.00	0.76	0.00
salivary acinar cells, donor1	11771-123I7	20.72	3.72	0.49	0.00	0.16	0.32	0.16	0.16
salivary acinar cells, donor2	11772-123I8	20.10	1.38	0.28	0.41	0.28	0.69	0.00	0.00
salivary acinar cells, donor3	11773-123I9	26.48	1.99	0.00	3.31	0.66	1.32	0.66	0.66
salivary gland, adult, pool1	10093-102C3	166.44	30.31	1.72	1.72	2.29	2.29	1.72	2.29
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	16.36	2.61	0.34	0.59	0.42	0.51	0.34	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	13.99	2.23	0.47	0.24	0.12	0.59	0.47	0.24
seminal vesicle, adult	10201-103F3	36.51	12.17	1.06	0.00	0.00	0.53	1.06	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	32.79	5.83	0.97	0.24	0.97	1.21	0.24	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	4.03	0.25	0.25	0.25	0.00	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	5.02	2.01	1.00	0.00	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	18.13	6.58	0.54	0.40	0.40	0.67	0.00	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	26.75	4.09	0.55	1.11	0.55	0.55	0.55	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	14.06	4.90	0.77	0.65	0.52	1.29	0.77	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	12.06	0.71	0.00	0.00	0.00	0.71	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	22.19	4.80	0.24	0.72	0.24	0.72	0.36	0.12
skeletal muscle, fetal, donor1	10066-101I3	10.05	5.03	1.01	0.00	0.00	0.00	1.01	0.00
skin, adult, donor1	10074-102A2	33.93	0.00	0.00	0.00	0.00	0.00	6.79	0.00
skin, fetal, donor1	10065-101I2	26.51	8.21	0.63	0.00	0.00	1.26	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	23.35	10.01	1.00	0.67	1.33	2.67	1.33	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	10.72	2.84	0.00	0.00	0.32	1.58	0.32	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	4.43	1.16	0.19	0.19	0.39	0.58	0.19	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	25.38	2.97	0.99	0.16	1.65	2.64	0.82	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	0.97	0.80	0.00	0.00	0.00	0.16	0.32	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	17.87	6.32	0.87	0.65	1.74	0.87	0.00	0.00
small intestine, adult, pool1	10024-101D6	54.94	12.78	1.67	3.58	0.36	0.72	0.72	0.24
small intestine, fetal, donor1	10064-101I1	20.64	6.88	0.49	2.46	0.00	0.25	0.49	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	49.24	17.95	1.03	0.00	5.64	2.05	0.00	1.03
smooth muscle, adult, pool1	10048-101G3	61.51	15.77	3.62	0.78	1.29	1.03	1.03	1.03
somatostatinoma cell line:QGP-1	10781-110G7	13.94	8.31	0.80	0.80	0.80	0.54	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	25.01	9.41	1.15	0.69	1.15	0.46	0.23	0.46
spinal cord, adult, donor10252	10159-103A6	34.70	14.59	2.37	1.97	1.58	0.39	0.79	0.00
spinal cord, adult, donor10258	10369-105F9	9.69	1.38	0.69	0.00	0.00	0.69	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	18.30	9.76	1.22	0.00	0.61	0.00	1.22	0.00
spinal cord, newborn, donor10223	10359-105E8	27.09	5.97	2.76	0.00	1.84	0.92	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	16.58	3.58	1.05	0.60	0.15	0.30	0.30	0.45
spleen, adult, pool1	10025-101D7	33.15	19.38	3.19	2.97	0.33	0.88	1.10	0.44
spleen, fetal, pool1	10044-101F8	37.11	33.69	5.56	1.83	1.43	0.64	1.03	0.87
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	36.02	48.75	3.00	2.79	1.24	0.31	1.04	1.24
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	85.63	14.62	2.47	1.14	2.85	3.23	1.33	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	5.24	0.70	0.00	0.35	0.00	0.35	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	43.78	4.69	1.17	1.56	0.39	0.39	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	48.29	4.95	1.69	0.79	0.79	3.04	1.01	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	4.66	2.12	0.00	0.00	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	8.46	2.12	0.00	0.00	0.00	0.42	0.42	0.00
stomach, fetal, donor1	10062-101H8	30.97	19.22	1.07	4.27	1.07	0.00	1.07	2.14
submaxillary gland, adult	10202-103F4	131.03	21.08	3.99	1.14	1.71	2.85	2.85	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	108.55	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	20.36	11.01	0.83	0.83	0.00	0.21	0.21	0.21
substantia nigra, adult, donor10258	10371-105G2	5.17	0.52	1.03	0.00	0.00	1.03	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	20.49	4.95	0.71	0.71	0.00	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	15.36	6.42	1.60	0.00	1.60	1.15	0.23	0.00
temporal lobe, adult, pool1	10031-101E4	12.38	3.65	1.02	0.42	0.76	0.59	0.93	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	6.41	0.71	0.00	0.00	0.00	0.71	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	7.03	3.08	0.00	0.44	0.88	0.44	0.44	0.44
tenocyte, donor1	11763-123H8	20.95	4.54	0.35	0.70	0.35	0.35	0.00	0.00
tenocyte, donor2	11765-123I1	16.40	2.29	0.00	1.14	0.38	0.38	0.38	0.00
tenocyte, donor3	11768-123I4	6.67	1.85	0.00	0.00	0.00	0.37	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	3.91	4.08	0.17	0.17	1.02	0.68	0.17	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	7.24	5.09	0.77	0.15	1.08	1.39	0.15	0.00
teratocarcinoma cell line:PA-1	10807-111A6	5.11	8.06	0.46	0.15	0.93	0.00	0.00	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	3.30	3.68	0.25	0.13	0.13	0.51	0.13	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	18.91	11.72	1.89	0.38	0.76	4.92	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	7.74	8.83	0.22	0.33	0.00	0.98	0.44	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	13.68	4.23	0.98	0.00	0.98	0.98	0.33	0.33
testis, adult, pool1	10026-101D8	22.44	6.98	2.04	1.50	0.32	0.64	1.29	0.11
testis, adult, pool2	10096-102C6	14.43	6.32	0.45	0.45	0.00	0.45	0.00	0.90
thalamus - adult, donor10196	10168-103B6	16.56	11.04	1.10	1.10	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	18.13	12.97	1.09	0.63	0.16	0.47	0.16	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	7.70	3.08	0.00	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	11.69	2.64	0.82	0.00	0.16	0.16	0.33	0.00
thalamus, newborn, donor10223	10366-105F6	9.78	0.58	0.00	0.00	0.00	0.00	0.58	0.58
throat, adult	10209-103G2	36.70	11.48	1.75	0.50	0.75	1.00	0.00	0.75
throat, fetal, donor1	10061-101H7	18.28	4.88	0.91	0.30	0.30	0.61	0.30	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	9.54	1.19	0.20	0.20	0.60	1.19	0.20	0.00
thymus, adult, pool1	10027-101D9	69.89	21.57	3.38	2.39	13.32	9.74	2.78	0.60
thymus, fetal, pool1	10043-101F7	95.07	39.17	7.27	3.01	22.96	12.88	4.05	1.14
thyroid carcinoma cell line:KHM-5M	10776-110G2	21.54	3.59	1.20	0.40	1.20	0.80	0.27	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	10.20	1.40	0.14	0.42	0.14	0.14	0.14	0.00
thyroid, adult, pool1	10028-101E1	24.07	11.38	0.84	0.75	0.19	0.00	0.47	0.37
thyroid, fetal, donor1	10060-101H6	37.97	10.81	2.11	0.79	0.79	1.05	0.53	0.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	92.39	15.40	3.08	3.08	0.00	0.00	0.00	3.08
tongue, adult	10203-103F5	27.21	6.28	1.40	0.47	0.00	0.93	0.47	0.00
tongue, fetal, donor1	10059-101H5	21.28	1.97	0.00	0.00	0.39	0.79	0.39	0.79
tonsil, adult, pool1	10047-101G2	58.10	26.25	4.81	3.81	1.40	2.10	1.50	0.70
trachea, adult, pool1	10029-101E2	58.00	23.15	2.62	1.64	1.23	1.39	0.57	0.65
trachea, fetal, donor1	10058-101H4	29.24	9.23	1.15	0.77	0.38	0.38	0.77	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	6.38	2.48	1.42	0.00	0.00	0.00	0.35	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	48.23	10.23	1.52	0.30	2.43	1.52	0.81	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	33.37	4.86	0.63	0.63	1.25	1.72	1.10	0.00
tridermal teratoma cell line:HGRT	10694-109G1	7.61	7.61	1.90	1.90	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	12.78	5.67	0.93	0.51	0.25	0.00	0.51	0.08
umbilical cord, fetal, donor1	10057-101H3	25.04	14.61	8.35	0.00	0.00	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	36.86	11.94	2.05	1.54	1.02	1.37	2.22	1.02
uterus, fetal, donor1	10055-101H1	15.36	4.10	1.02	0.51	0.51	1.02	0.51	0.00
vagina, adult	10204-103F6	43.94	10.99	0.65	0.65	1.29	0.00	0.00	0.00
vein, adult	10191-103E2	23.89	17.54	2.19	1.10	2.19	0.44	0.66	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	4.81	17.62	0.53	2.14	0.27	0.00	0.27	0.00